data_2k1b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1b _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.242 0.665 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.539 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.428 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.578 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 24' ' ' LYS . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 7.3 m-70 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.498 HD13 HG13 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.578 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.715 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HG13 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.45 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.553 HG13 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.597 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 m-70 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 HD11 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG23 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 26' ' ' LYS . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.687 HD13 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.24 0.566 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 HG23 ' HB ' ' A' ' 23' ' ' VAL . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' HB ' HG23 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 5' ' ' ALA . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.239 0.523 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 HG11 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG21 HG23 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HB ' HD12 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.647 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.531 HG11 HD11 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.784 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD2' HG23 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.531 HD11 HG11 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 . . . . . 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.243 0.763 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.487 HG11 HD12 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HD2' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.472 HD11 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.513 HD23 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.502 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.566 HD12 ' HB1' ' A' ' 5' ' ' ALA . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.463 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.463 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG11 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HD1' ' A' ' 40' ' ' HIS . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HD1' ' HG3' ' A' ' 39' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG13 HD13 ' A' ' 46' ' ' LEU . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.448 HG23 HG21 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' O ' HG11 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD13 HG13 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.511 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.593 HG12 HG11 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HD2' HG22 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB2' HD13 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.436 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.648 HD12 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 HG11 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.648 ' HB ' HD12 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.544 HG11 HD12 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.418 ' H ' HG23 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG21 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.433 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.414 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 9.4 m170 -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HG11 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.586 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.561 0 CA-C-O 121.114 0.483 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.424 HG23 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB3' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.46 HG23 HG21 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.427 ' HG ' HD13 ' A' ' 22' ' ' LEU . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.601 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.949 0.404 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.457 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.663 ' HB ' HG23 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.457 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.584 HD12 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' HB ' HD12 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.466 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.558 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.428 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 HD11 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD22 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HD2' HD21 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.486 HG21 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.413 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HG2' HD12 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.501 HD12 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.41 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.58 -43.12 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.367 0.667 . . . . 0.0 110.591 -175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 85.01 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.238 1.018 . . . . 0.0 109.529 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -88.5 102.69 15.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.423 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 46' ' ' LEU . . . -140.13 166.98 23.21 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.122 0.969 . . . . 0.0 110.089 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.647 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.469 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.468 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.647 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.673 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.539 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.468 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -80.48 -36.05 33.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -81.43 -178.57 7.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -89.62 136.28 33.12 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.145 0.978 . . . . 0.0 111.206 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.257 1.466 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.422 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.51 81.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.233 1.013 . . . . 0.0 111.443 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.95 29.68 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.03 1.332 . . . . 0.0 108.71 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -74.89 106.31 6.35 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.81 0.844 . . . . 0.0 109.657 -173.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.04 162.86 34.4 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.276 1.03 . . . . 0.0 109.543 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.498 HG13 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.428 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.578 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HB3' ' HZ1' ' A' ' 16' ' ' LYS . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.428 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 24' ' ' LYS . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.533 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 7.3 m-70 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.443 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.498 HD13 HG13 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.578 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.564 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 -86.22 -44.66 11.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -85.35 144.54 27.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.803 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.88 -61.77 1.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.779 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 65.09 2.18 1.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.12 94.6 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.68 95.05 9.92 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.51 179.74 6.1 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.999 1.32 . . . . 0.0 109.456 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.553 HG12 HG13 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.45 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.553 HG13 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.597 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.597 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 m-70 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.03 -50.4 5.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -83.14 147.24 28.19 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.266 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.75 5.76 50.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.174 0.99 . . . . 0.0 110.252 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 111.195 -174.468 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -84.5 -12.9 53.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.18 95.56 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.81 96.66 10.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.687 ' HB1' HD13 ' A' ' 46' ' ' LEU . . . -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.213 1.005 . . . . 0.0 109.602 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.578 HG12 HD11 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.678 ' HZ2' ' HB2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG23 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 26' ' ' LYS . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.557 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.441 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.573 ' O ' HG13 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.687 HD13 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.489 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.459 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 -83.97 -36.17 23.41 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 70.9 mmtt -82.26 161.99 22.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.205 0.602 . . . . 0.0 109.989 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -74.45 -50.05 19.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.209 0.603 . . . . 0.0 110.896 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 125.198 1.399 . . . . 0.0 109.194 -174.062 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -146.23 -34.06 0.31 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.964 0.506 . . . . 0.0 111.018 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -83.56 81.97 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.02 0.914 . . . . 0.0 109.526 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -99.21 117.68 34.23 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.625 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 46' ' ' LEU . . . -102.64 -179.72 4.05 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.582 1.153 . . . . 0.0 109.846 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 HG23 ' HB ' ' A' ' 23' ' ' VAL . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.492 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' HB ' HG23 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.4 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 5' ' ' ALA . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.554 ' HB ' HD12 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.517 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.46 -34.96 18.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.7 mmpt? -82.23 -30.47 30.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.488 0.715 . . . . 0.0 110.345 -174.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.99 130.14 39.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.108 0.48 . . . . 0.0 110.007 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.823 0.849 . . . . 0.0 109.37 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 60.1 57.38 3.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.588 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.38 36.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.943 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.98 93.53 2.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.789 0.836 . . . . 0.0 110.341 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.438 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -141.72 -179.69 6.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG22 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.459 HG12 HG11 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.504 HG23 HG21 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG21 HG23 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' HB ' HG22 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.44 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.571 HD12 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 HD12 HG11 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' HB ' HD12 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -90.96 -59.43 2.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.83 122.82 26.55 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.488 0.715 . . . . 0.0 109.538 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.96 115.16 20.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.297 0.639 . . . . 0.0 110.207 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 . . . . . 0 CA--C 1.554 1.127 0 C-N-CA 123.174 0.59 . . . . 0.0 109.717 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.239 0.066 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.51 -1.33 10.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.309 0.644 . . . . 0.0 112.247 -170.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.96 85.11 2.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.06 77.88 3.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.72 162.56 15.5 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.367 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.531 HG11 HD11 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.442 HG23 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.559 HG21 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.784 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.784 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.559 HG22 HG21 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.442 ' HD2' HG23 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.529 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.531 HD11 HG11 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.634 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.634 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 -80.0 -36.86 35.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 11.1 mmpt? -78.92 169.3 18.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.029 0.442 . . . . 0.0 110.646 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.23 117.6 21.81 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.281 175.904 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.648 0.261 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -126.54 13.68 7.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.937 0.895 . . . . 0.0 111.478 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.8 m -87.97 88.21 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -76.06 81.54 2.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD23 ' A' ' 46' ' ' LEU . . . -140.14 162.25 35.69 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.942 -171.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.487 HG11 HD12 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.472 ' HD2' HD11 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.453 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HZ2' ' HB2' ' A' ' 16' ' ' LYS . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.568 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG21 HG21 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.472 HD11 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.52 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.421 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.52 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.52 HD12 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.513 HD23 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.52 ' HB ' HD12 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -89.41 -43.73 10.67 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -89.15 153.35 21.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.161 0.985 . . . . 0.0 109.376 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.86 -43.88 74.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.452 0.701 . . . . 0.0 111.288 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 123.96 0.904 . . . . 0.0 108.701 176.4 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -77.91 77.1 4.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.382 0.673 . . . . 0.0 109.927 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 p -166.34 79.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.914 1.286 . . . . 0.0 108.259 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.55 84.12 6.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.568 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 46' ' ' LEU . . . -121.97 178.14 5.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.9 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.548 HG11 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.454 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.502 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG22 HG23 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.464 HG23 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.454 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.566 HD12 ' HB1' ' A' ' 5' ' ' ALA . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 -52.02 5.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -70.45 169.65 13.62 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.065 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 67.37 93.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.179 1.392 . . . . 0.0 110.692 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.152 0.981 . . . . 0.0 109.424 176.024 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.458 0.17 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 56.75 46.39 20.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.619 1.168 . . . . 0.0 111.392 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.01 63.83 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 122.064 0.935 . . . . 0.0 108.704 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -128.72 126.3 39.75 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.835 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.05 179.63 6.62 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.181 0.992 . . . . 0.0 108.904 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.463 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.521 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.521 HG23 HG21 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.521 HG21 HG23 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.463 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG11 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.474 ' HG3' ' HD1' ' A' ' 40' ' ' HIS . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HD1' ' HG3' ' A' ' 39' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.497 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.84 -36.47 59.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.411 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 10.2 mmpt? -81.92 -44.49 16.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.088 0.555 . . . . 0.0 109.676 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 61.83 98.58 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.392 1.077 . . . . 0.0 111.609 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.403 0.681 . . . . 0.0 111.059 -175.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 67.63 -3.24 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.218 1.407 . . . . 0.0 113.375 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -94.3 58.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.162 0.985 . . . . 0.0 109.572 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -76.59 85.15 3.27 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.077 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.5 178.29 5.48 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.159 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG13 HD13 ' A' ' 46' ' ' LEU . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.448 HG21 HG23 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.442 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.448 HG23 HG21 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.53 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.444 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.54 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' O ' HG11 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD13 HG13 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG11 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.543 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.511 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 -85.09 -42.91 14.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 69.8 mmtt -87.21 153.75 21.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.954 -177.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.47 -33.74 65.01 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.873 . . . . 0.0 111.414 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.604 0.762 . . . . 0.0 110.634 -175.585 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.08 -8.29 1.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.102 1.761 . . . . 0.0 113.763 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.95 71.78 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.82 0.819 . . . . 0.0 108.814 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.45 93.11 7.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.422 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.79 -177.58 3.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.445 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.593 HG12 HG11 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.432 ' HD2' HG22 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.528 HD13 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.593 HG11 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HZ2' ' HB3' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.528 ' HB2' HD13 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.46 -27.72 69.18 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -92.22 2.48 56.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.89 98.41 4.15 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.176 0.591 . . . . 0.0 110.334 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 . . . . . 0 CA--C 1.562 1.414 0 C-N-CA 125.263 1.425 . . . . 0.0 112.136 173.527 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 75.44 -42.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.874 1.669 . . . . 0.0 115.141 166.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 p -94.15 124.71 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.705 0.802 . . . . 0.0 109.313 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -123.15 70.78 1.03 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.67 7.25 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.164 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.562 HG22 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.479 HD13 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG23 HG21 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG21 HG23 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' HB ' HG22 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.436 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.436 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.648 HD12 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 HG11 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.648 ' HB ' HD12 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.5 -43.09 10.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -98.97 167.47 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.44 1.096 . . . . 0.0 109.778 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -97.94 -81.75 0.43 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.579 0.352 . . . . 0.0 110.289 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.363 1.065 . . . . 0.0 109.149 -178.109 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 67.56 3.08 3.21 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.466 1.506 . . . . 0.0 113.269 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.74 90.36 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.61 95.85 6.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.784 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.37 163.09 28.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.216 0.606 . . . . 0.0 110.194 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.544 HG11 HD12 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.418 ' H ' HG23 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.406 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.586 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.458 HG22 HG21 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG21 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.433 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.489 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.404 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.414 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 9.4 m170 -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.544 HD12 HG11 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.586 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 -88.86 -42.67 11.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -90.4 168.44 11.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.307 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.82 58.14 0.63 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 108.564 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.632 1.173 . . . . 0.0 109.687 -175.02 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -104.61 25.57 10.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.008 0.923 . . . . 0.0 110.819 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.44 72.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.854 0.835 . . . . 0.0 110.931 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -82.78 86.46 6.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.756 0.789 . . . . 0.0 108.888 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.58 -179.48 5.31 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.514 -170.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.424 HG23 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.431 ' HB3' HD22 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.601 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.46 HG23 HG21 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' HD2' HG23 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.427 ' HG ' HD13 ' A' ' 22' ' ' LEU . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.505 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.495 HD11 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.615 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.601 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.615 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 -67.18 -52.62 39.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.424 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 11.4 mmpt? -80.2 -42.68 22.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.699 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 60.32 98.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.802 1.241 . . . . 0.0 109.721 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 124.821 1.249 . . . . 0.0 113.519 -174.373 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 60.36 23.86 13.37 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.185 1.394 . . . . 0.0 112.538 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.03 121.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 109.783 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.87 91.15 3.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.1 167.39 21.94 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.198 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.508 HG12 HD11 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.457 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.558 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.663 ' HB ' HG23 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.481 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.663 HG23 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.457 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.721 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.428 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.584 HD12 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.485 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.508 HD11 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' HB ' HD12 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.485 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.558 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 -90.0 -24.22 21.29 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 72.2 mmtt -97.52 159.51 14.88 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.486 0.714 . . . . 0.0 109.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -80.79 -38.1 29.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.347 0.659 . . . . 0.0 109.798 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.25 1.093 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.041 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -67.17 -22.87 65.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.58 0.752 . . . . 0.0 111.478 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.97 100.29 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -94.17 99.33 11.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.27 177.83 6.88 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.611 0.764 . . . . 0.0 110.803 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 HD11 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD22 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.481 HG21 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 HG22 HG21 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -77.73 -42.54 33.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -80.98 -19.18 44.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.42 83.88 7.56 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 123.801 0.84 . . . . 0.0 109.174 -177.489 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 67.63 7.87 5.96 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.141 1.376 . . . . 0.0 112.826 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.67 140.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 109.176 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -150.4 155.45 39.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.568 0.747 . . . . 0.0 109.806 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.82 178.33 7.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 109.935 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.514 ' HD2' HD21 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.535 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.446 HG21 HG23 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.446 HG23 HG21 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.514 HD21 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.581 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.556 HD12 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.535 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -82.17 -47.63 12.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -70.61 99.06 1.59 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.059 0.457 . . . . 0.0 109.822 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.74 1.2 52.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.675 1.19 . . . . 0.0 111.715 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 123.964 0.905 . . . . 0.0 110.063 177.573 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -83.07 29.71 0.47 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.184 0.993 . . . . 0.0 112.815 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.34 93.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -96.44 84.08 3.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.865 0.84 . . . . 0.0 108.93 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 -177.52 5.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.392 1.477 . . . . 0.0 108.673 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.603 HG23 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.525 ' HD2' HD21 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.486 HG21 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.486 HG22 HG21 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.525 HD21 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.603 ' HB ' HG23 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.566 ' HZ2' ' HB3' ' A' ' 26' ' ' LYS . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.525 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.469 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.579 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 -54.81 -42.04 71.38 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 66.6 mmtt -89.64 -53.51 4.49 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.148 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -90.7 77.08 6.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.2 0.6 . . . . 0.0 110.891 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 123.935 0.894 . . . . 0.0 109.621 176.574 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.577 ' HG2' ' HG3' ' A' ' 2' ' ' GLN . 36.7 tt0 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.577 ' HG3' ' HG2' ' A' ' 1' ' ' GLU . 49.2 mt-30 67.51 3.98 3.6 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.585 1.154 . . . . 0.0 113.237 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.49 90.98 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.79 131.83 40.21 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.493 ' HB2' HD21 ' A' ' 46' ' ' LEU . . . -133.07 151.04 52.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.605 1.162 . . . . 0.0 108.881 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD12 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.447 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.435 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.413 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.55 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.611 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.501 ' HG2' HD12 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.501 HD12 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.522 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -88.39 -36.63 16.46 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.9 mmpt? -77.82 -16.18 58.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.023 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 13.9 mm-40 -73.9 90.07 1.91 Allowed 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.532 -175.352 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.242 0.665 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 10' ' ' ARG . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.689 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.576 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.475 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.617 HD21 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.715 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 46' ' ' LEU . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.46 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 21' ' ' TYR . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 6' ' ' VAL . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.409 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' O ' HG12 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.716 HD11 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.24 0.566 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 46' ' ' LEU . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' HB ' HG21 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 6' ' ' VAL . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.239 0.523 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HG12 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.581 ' HB ' HD13 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.647 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD13 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.803 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.803 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.507 ' HD2' HG21 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD13 HG12 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 . . . . . 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.243 0.763 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD13 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD21 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.522 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.558 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.527 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.401 ' H ' HG22 ' A' ' 6' ' ' VAL . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.579 HD13 HG12 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 29' ' ' PRO . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 23' ' ' VAL . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.438 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' H ' HD12 ' A' ' 46' ' ' LEU . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 43' ' ' ASP . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.414 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.48 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.561 0 CA-C-O 121.114 0.483 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.949 0.404 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.543 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.589 HD13 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.484 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.428 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.481 HG12 HD13 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.66 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD23 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 41' ' ' ILE . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.58 -43.12 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.367 0.667 . . . . 0.0 110.591 -175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 85.01 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.238 1.018 . . . . 0.0 109.529 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -88.5 102.69 15.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.423 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -140.13 166.98 23.21 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.122 0.969 . . . . 0.0 110.089 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 10' ' ' ARG . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.689 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.576 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.475 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.617 HD21 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -80.48 -36.05 33.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -81.43 -178.57 7.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -89.62 136.28 33.12 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.145 0.978 . . . . 0.0 111.206 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.257 1.466 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.422 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.51 81.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.233 1.013 . . . . 0.0 111.443 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.95 29.68 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.03 1.332 . . . . 0.0 108.71 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -74.89 106.31 6.35 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.81 0.844 . . . . 0.0 109.657 -173.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.04 162.86 34.4 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.276 1.03 . . . . 0.0 109.543 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 -86.22 -44.66 11.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -85.35 144.54 27.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.803 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.88 -61.77 1.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.779 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 65.09 2.18 1.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.12 94.6 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.68 95.05 9.92 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.51 179.74 6.1 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.999 1.32 . . . . 0.0 109.456 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 46' ' ' LEU . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.46 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 21' ' ' TYR . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 6' ' ' VAL . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.03 -50.4 5.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -83.14 147.24 28.19 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.266 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.75 5.76 50.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.174 0.99 . . . . 0.0 110.252 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 111.195 -174.468 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -84.5 -12.9 53.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.18 95.56 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.81 96.66 10.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.213 1.005 . . . . 0.0 109.602 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.409 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' O ' HG12 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.716 HD11 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 -83.97 -36.17 23.41 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 70.9 mmtt -82.26 161.99 22.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.205 0.602 . . . . 0.0 109.989 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -74.45 -50.05 19.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.209 0.603 . . . . 0.0 110.896 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 125.198 1.399 . . . . 0.0 109.194 -174.062 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -146.23 -34.06 0.31 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.964 0.506 . . . . 0.0 111.018 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -83.56 81.97 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.02 0.914 . . . . 0.0 109.526 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -99.21 117.68 34.23 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.625 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -102.64 -179.72 4.05 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.582 1.153 . . . . 0.0 109.846 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 46' ' ' LEU . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' HB ' HG21 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 6' ' ' VAL . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.46 -34.96 18.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.7 mmpt? -82.23 -30.47 30.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.488 0.715 . . . . 0.0 110.345 -174.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.99 130.14 39.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.108 0.48 . . . . 0.0 110.007 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.823 0.849 . . . . 0.0 109.37 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 60.1 57.38 3.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.588 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.38 36.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.943 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.98 93.53 2.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.789 0.836 . . . . 0.0 110.341 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -141.72 -179.69 6.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HG12 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.581 ' HB ' HD13 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -90.96 -59.43 2.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.83 122.82 26.55 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.488 0.715 . . . . 0.0 109.538 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.96 115.16 20.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.297 0.639 . . . . 0.0 110.207 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 . . . . . 0 CA--C 1.554 1.127 0 C-N-CA 123.174 0.59 . . . . 0.0 109.717 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.239 0.066 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.51 -1.33 10.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.309 0.644 . . . . 0.0 112.247 -170.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.96 85.11 2.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.06 77.88 3.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.72 162.56 15.5 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.367 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD13 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.803 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.803 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.507 ' HD2' HG21 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD13 HG12 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 -80.0 -36.86 35.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 11.1 mmpt? -78.92 169.3 18.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.029 0.442 . . . . 0.0 110.646 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.23 117.6 21.81 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.281 175.904 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.648 0.261 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -126.54 13.68 7.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.937 0.895 . . . . 0.0 111.478 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.8 m -87.97 88.21 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -76.06 81.54 2.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -140.14 162.25 35.69 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.942 -171.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD13 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD21 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -89.41 -43.73 10.67 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -89.15 153.35 21.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.161 0.985 . . . . 0.0 109.376 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.86 -43.88 74.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.452 0.701 . . . . 0.0 111.288 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 123.96 0.904 . . . . 0.0 108.701 176.4 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -77.91 77.1 4.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.382 0.673 . . . . 0.0 109.927 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 p -166.34 79.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.914 1.286 . . . . 0.0 108.259 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.55 84.12 6.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.568 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -121.97 178.14 5.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.9 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.522 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 -52.02 5.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -70.45 169.65 13.62 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.065 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 67.37 93.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.179 1.392 . . . . 0.0 110.692 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.152 0.981 . . . . 0.0 109.424 176.024 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.458 0.17 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 56.75 46.39 20.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.619 1.168 . . . . 0.0 111.392 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.01 63.83 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 122.064 0.935 . . . . 0.0 108.704 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -128.72 126.3 39.75 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.835 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.05 179.63 6.62 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.181 0.992 . . . . 0.0 108.904 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.558 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.527 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.84 -36.47 59.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 10.2 mmpt? -81.92 -44.49 16.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.088 0.555 . . . . 0.0 109.676 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 61.83 98.58 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.392 1.077 . . . . 0.0 111.609 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.403 0.681 . . . . 0.0 111.059 -175.937 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 67.63 -3.24 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.218 1.407 . . . . 0.0 113.375 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -94.3 58.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.162 0.985 . . . . 0.0 109.572 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -76.59 85.15 3.27 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.077 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.5 178.29 5.48 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.159 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.401 ' H ' HG22 ' A' ' 6' ' ' VAL . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.579 HD13 HG12 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 -85.09 -42.91 14.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 69.8 mmtt -87.21 153.75 21.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.954 -177.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.47 -33.74 65.01 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.873 . . . . 0.0 111.414 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.604 0.762 . . . . 0.0 110.634 -175.585 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.08 -8.29 1.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.102 1.761 . . . . 0.0 113.763 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.95 71.78 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.82 0.819 . . . . 0.0 108.814 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.45 93.11 7.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.422 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.79 -177.58 3.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.445 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.46 -27.72 69.18 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -92.22 2.48 56.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.89 98.41 4.15 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.176 0.591 . . . . 0.0 110.334 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 . . . . . 0 CA--C 1.562 1.414 0 C-N-CA 125.263 1.425 . . . . 0.0 112.136 173.527 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 75.44 -42.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.874 1.669 . . . . 0.0 115.141 166.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 p -94.15 124.71 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.705 0.802 . . . . 0.0 109.313 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -123.15 70.78 1.03 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.67 7.25 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.164 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 29' ' ' PRO . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 23' ' ' VAL . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.438 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' H ' HD12 ' A' ' 46' ' ' LEU . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 43' ' ' ASP . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.5 -43.09 10.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -98.97 167.47 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.44 1.096 . . . . 0.0 109.778 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -97.94 -81.75 0.43 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.579 0.352 . . . . 0.0 110.289 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.363 1.065 . . . . 0.0 109.149 -178.109 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 67.56 3.08 3.21 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.466 1.506 . . . . 0.0 113.269 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.74 90.36 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.61 95.85 6.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.784 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.37 163.09 28.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.216 0.606 . . . . 0.0 110.194 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.414 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 -88.86 -42.67 11.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -90.4 168.44 11.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.307 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.82 58.14 0.63 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 108.564 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.632 1.173 . . . . 0.0 109.687 -175.02 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -104.61 25.57 10.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.008 0.923 . . . . 0.0 110.819 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.44 72.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.854 0.835 . . . . 0.0 110.931 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -82.78 86.46 6.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.756 0.789 . . . . 0.0 108.888 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.58 -179.48 5.31 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.514 -170.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 -67.18 -52.62 39.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 11.4 mmpt? -80.2 -42.68 22.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.699 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 60.32 98.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.802 1.241 . . . . 0.0 109.721 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 124.821 1.249 . . . . 0.0 113.519 -174.373 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 60.36 23.86 13.37 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.185 1.394 . . . . 0.0 112.538 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.03 121.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 109.783 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.87 91.15 3.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.1 167.39 21.94 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.198 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.543 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.589 HD13 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.484 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 -90.0 -24.22 21.29 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 72.2 mmtt -97.52 159.51 14.88 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.486 0.714 . . . . 0.0 109.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -80.79 -38.1 29.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.347 0.659 . . . . 0.0 109.798 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.25 1.093 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.041 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -67.17 -22.87 65.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.58 0.752 . . . . 0.0 111.478 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.97 100.29 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -94.17 99.33 11.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.27 177.83 6.88 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.611 0.764 . . . . 0.0 110.803 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.481 HG12 HD13 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -77.73 -42.54 33.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -80.98 -19.18 44.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.42 83.88 7.56 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 123.801 0.84 . . . . 0.0 109.174 -177.489 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 67.63 7.87 5.96 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.141 1.376 . . . . 0.0 112.826 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.67 140.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 109.176 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -150.4 155.45 39.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.568 0.747 . . . . 0.0 109.806 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.82 178.33 7.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 109.935 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -82.17 -47.63 12.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -70.61 99.06 1.59 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.059 0.457 . . . . 0.0 109.822 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.74 1.2 52.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.675 1.19 . . . . 0.0 111.715 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 123.964 0.905 . . . . 0.0 110.063 177.573 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -83.07 29.71 0.47 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.184 0.993 . . . . 0.0 112.815 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.34 93.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -96.44 84.08 3.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.865 0.84 . . . . 0.0 108.93 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 -177.52 5.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.392 1.477 . . . . 0.0 108.673 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.66 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD23 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 -54.81 -42.04 71.38 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 66.6 mmtt -89.64 -53.51 4.49 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.148 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -90.7 77.08 6.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.2 0.6 . . . . 0.0 110.891 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 123.935 0.894 . . . . 0.0 109.621 176.574 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 2' ' ' GLN . 36.7 tt0 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' A' ' 1' ' ' GLU . 49.2 mt-30 67.51 3.98 3.6 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.585 1.154 . . . . 0.0 113.237 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.49 90.98 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.79 131.83 40.21 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -133.07 151.04 52.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.605 1.162 . . . . 0.0 108.881 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 41' ' ' ILE . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -88.39 -36.63 16.46 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.9 mmpt? -77.82 -16.18 58.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.023 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 13.9 mm-40 -73.9 90.07 1.91 Allowed 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.532 -175.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.242 0.665 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 10' ' ' ARG . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.689 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.576 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.475 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.617 HD21 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 . . . . . 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.593 0 N-CA-C 109.543 -0.539 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.53 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 7.3 m-70 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 . . . . . 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.715 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 46' ' ' LEU . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.46 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.607 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 m-70 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 21' ' ' TYR . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 6' ' ' VAL . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 . . . . . 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.409 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.583 ' O ' HG12 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.716 HD11 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 . . . . . 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.24 0.566 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 46' ' ' LEU . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 ' HB ' HG21 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 6' ' ' VAL . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.239 0.523 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HG12 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.581 ' HB ' HD13 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.647 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD13 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.507 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.803 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.803 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.507 ' HD2' HG21 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.582 HD13 HG12 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 . . . . . 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 C--O 1.243 0.763 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.477 HD13 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD21 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.522 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.49 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.558 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.558 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.527 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.308 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.58 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.401 ' H ' HG22 ' A' ' 6' ' ' VAL . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.579 HD13 HG12 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 110.445 -0.205 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 120.803 0.335 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 29' ' ' PRO . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 23' ' ' VAL . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.438 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.415 ' H ' HD12 ' A' ' 46' ' ' LEU . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 43' ' ' ASP . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.414 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.48 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.42 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.42 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 9.4 m170 -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 . . . . . 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.561 0 CA-C-O 121.114 0.483 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.49 0 CA-C-O 120.949 0.404 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.543 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.589 HD13 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.484 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 . . . . . 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 121.0 0.428 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.481 HG12 HD13 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 . . . . . 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.579 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.66 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD23 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 41' ' ' ILE . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.427 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 . . . . . 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -143.58 -43.12 0.28 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.367 0.667 . . . . 0.0 110.591 -175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.6 p -88.78 85.01 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-O 122.238 1.018 . . . . 0.0 109.529 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -88.5 102.69 15.17 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.423 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.617 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -140.13 166.98 23.21 Favored 'General case' 0 C--O 1.242 0.665 0 C-N-CA 124.122 0.969 . . . . 0.0 110.089 -177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.689 HG21 ' HB ' ' A' ' 23' ' ' VAL . 3.8 p -73.6 155.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.063 0.545 . . . . 0.0 110.797 -176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.469 ' HB2' ' HG3' ' A' ' 26' ' ' LYS . 30.6 tt0 -54.91 -47.99 73.64 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.085 0.554 . . . . 0.0 110.531 -178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 p -174.88 174.12 2.6 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.512 1.525 . . . . 0.0 108.565 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 59.9 mt -102.94 119.86 51.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 169.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -66.2 -47.32 74.29 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.513 1.125 . . . . 0.0 110.157 -174.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -159.16 163.02 36.43 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.735 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.54 159.75 34.51 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 170.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -156.85 148.51 22.53 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.986 0.914 . . . . 0.0 108.848 174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.5 t -85.62 124.01 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 174.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.28 127.08 17.16 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -170.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.8 pttp 47.61 37.61 6.93 Favored 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 124.989 1.316 . . . . 0.0 113.281 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.24 12.67 84.38 Favored Glycine 0 C--N 1.351 1.404 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.171 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -131.65 139.11 49.01 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.774 0.83 . . . . 0.0 109.564 -178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -78.88 111.66 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.475 ' HB3' ' HE3' ' A' ' 35' ' ' TRP . 0.5 OUTLIER -97.17 140.11 32.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.683 1.193 . . . . 0.0 108.692 177.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -120.82 115.94 24.23 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.307 0.643 . . . . 0.0 110.806 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.42 HD23 ' HD2' ' A' ' 10' ' ' ARG . 46.6 tp -76.88 107.79 9.46 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 170.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.689 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.9 m -80.6 163.9 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.51 0.724 . . . . 0.0 112.193 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.43 ' O ' HG22 ' A' ' 6' ' ' VAL . 1.9 tmtp? -123.63 112.02 16.91 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 172.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 62.2 m95 -80.08 147.26 31.51 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.339 0.656 . . . . 0.0 109.761 178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.469 ' HG3' ' HB2' ' A' ' 7' ' ' GLU . 3.6 mppt? -64.87 111.03 2.64 Favored 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.988 0.358 . . . . 0.0 110.726 -176.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.95 -0.62 86.39 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.872 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.68 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.6 m95 -115.15 128.89 25.54 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-N 117.807 0.804 . . . . 0.0 110.017 -178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.21 155.55 67.88 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 122.505 2.137 . . . . 0.0 111.479 174.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -65.67 2.21 1.76 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 123.114 2.543 . . . . 0.0 114.694 -174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -70.15 -25.89 63.67 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.564 0.346 . . . . 0.0 111.221 169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -94.22 6.44 48.61 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.828 0.851 . . . . 0.0 111.062 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.576 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 42.8 t -77.22 170.64 16.18 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.774 0.797 . . . . 0.0 111.926 -175.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.6 p -131.96 122.19 25.17 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.356 -1.293 . . . . 0.0 108.7 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.475 ' HE3' ' HB3' ' A' ' 20' ' ' GLU . 78.9 m95 -70.51 102.26 2.18 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -114.38 137.07 22.41 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 123.459 0.703 . . . . 0.0 109.628 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.97 178.98 5.8 Favored 'Trans proline' 0 C--N 1.368 1.604 0 C-N-CA 122.37 2.047 . . . . 0.0 113.45 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -51.21 -32.82 25.19 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.369 1.468 . . . . 0.0 112.664 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' H ' ' HG2' ' A' ' 39' ' ' GLU . 9.0 pt-20 -91.11 -12.59 35.12 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.029 -170.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 66.4 m170 -105.83 4.87 30.23 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.531 0.332 . . . . 0.0 111.269 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.1 mt -70.97 137.37 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.86 -29.54 67.87 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -175.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -161.67 142.54 8.24 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 122.16 0.184 . . . . 0.0 110.655 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.76 -24.48 9.99 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 124.558 3.506 . . . . 0.0 115.534 171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -66.06 -25.67 67.14 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.542 0.337 . . . . 0.0 110.797 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.617 HD21 ' HB1' ' A' ' 5' ' ' ALA . 66.7 mt -79.68 -40.87 28.06 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.601 0.761 . . . . 0.0 111.52 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.4 p -61.91 -44.53 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.7 ptm -76.59 -17.5 59.17 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.466 0.706 . . . . 0.0 111.289 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.7 -22.79 67.06 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.421 0.689 . . . . 0.0 110.722 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 9' ' ' ILE . 68.2 t80 -92.78 -58.75 2.24 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.292 165.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -56.63 -52.71 63.82 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 124.27 1.028 . . . . 0.0 112.369 -166.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -80.48 -36.05 33.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.785 -177.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -81.43 -178.57 7.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.281 0.562 . . . . 0.0 111.641 -176.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -89.62 136.28 33.12 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.145 0.978 . . . . 0.0 111.206 -178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--O 1.257 1.466 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 169.422 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -61.51 81.06 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.233 1.013 . . . . 0.0 111.443 174.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.3 m -136.95 29.68 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 125.03 1.332 . . . . 0.0 108.71 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -74.89 106.31 6.35 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.81 0.844 . . . . 0.0 109.657 -173.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.04 162.86 34.4 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.276 1.03 . . . . 0.0 109.543 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 11.1 p -70.83 154.44 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.3 0.64 . . . . 0.0 110.796 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -55.26 -59.23 5.07 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 167.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.5 t -175.49 152.98 1.41 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.346 1.058 . . . . 0.0 108.615 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.448 HG21 ' HD2' ' A' ' 21' ' ' TYR . 67.1 mt -86.07 114.57 25.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 172.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.48 -53.47 8.61 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.297 0.639 . . . . 0.0 109.789 -176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.57 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.3 ptpt -150.46 163.77 37.59 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.528 0.731 . . . . 0.0 110.113 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -123.87 170.64 10.37 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.19 0.519 . . . . 0.0 111.113 176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -155.91 145.59 21.12 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.91 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.1 t -110.27 114.7 47.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 167.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.54 146.31 26.5 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 56.32 25.48 9.45 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 126.313 1.845 . . . . 0.0 113.397 -175.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.87 26.35 74.47 Favored Glycine 0 C--N 1.344 1.017 0 CA-C-N 116.41 -0.359 . . . . 0.0 112.525 -175.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -129.58 145.56 51.47 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.604 1.162 . . . . 0.0 109.133 -177.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.6 t -103.92 110.37 29.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 175.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 10.0 pt-20 -118.77 148.24 43.03 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.184 0.994 . . . . 0.0 110.248 -174.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.448 ' HD2' HG21 ' A' ' 9' ' ' ILE . 77.0 m-85 -125.87 122.67 36.73 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.149 0.98 . . . . 0.0 109.482 -173.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.9 tp -64.75 105.29 0.96 Allowed 'General case' 0 C--O 1.239 0.521 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.06 129.56 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.033 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 4.4 mmmp? -84.38 134.43 34.48 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 175.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 23.2 m95 -91.81 132.96 36.05 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -66.2 111.92 3.68 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.416 0.686 . . . . 0.0 110.389 -176.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.53 17.94 65.16 Favored Glycine 0 CA--C 1.532 1.11 0 O-C-N 123.547 0.53 . . . . 0.0 113.391 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.511 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 94.6 m95 -126.77 139.9 36.13 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 123.417 0.687 . . . . 0.0 110.199 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -63.58 162.6 27.21 Favored 'Trans proline' 0 CA--C 1.563 1.964 0 C-N-CA 123.271 2.647 . . . . 0.0 113.129 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.52 -18.77 20.87 Favored 'Trans proline' 0 C--N 1.386 2.5 0 C-N-CA 123.626 2.884 . . . . 0.0 115.3 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -71.27 -27.2 63.27 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -88.25 -13.89 39.8 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 122.862 0.465 . . . . 0.0 111.266 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.42 ' HA ' ' CD1' ' A' ' 25' ' ' TRP . 41.0 m -69.8 113.23 6.85 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 122.776 0.43 . . . . 0.0 109.876 -179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 48.6 p -89.96 171.87 9.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.982 0.913 . . . . 0.0 111.325 -174.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -110.47 102.92 11.49 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.565 0.746 . . . . 0.0 109.031 175.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -98.25 121.32 57.39 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.886 0.874 . . . . 0.0 109.865 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 42.1 Cg_endo -66.49 179.42 2.08 Favored 'Trans proline' 0 C--N 1.37 1.698 0 C-N-CA 122.397 2.065 . . . . 0.0 112.262 174.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 14.0 mt-10 -66.25 -12.09 54.18 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -176.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.53 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 10.2 pt-20 -91.6 -11.4 37.29 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.964 0.905 . . . . 0.0 112.297 178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.53 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 7.3 m-70 -108.06 19.97 19.3 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.591 0.756 . . . . 0.0 111.648 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.535 HD13 ' HB ' ' A' ' 47' ' ' VAL . 8.9 mt -91.14 138.22 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -82.93 -37.21 24.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.686 0.394 . . . . 0.0 110.957 -175.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.444 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 15.4 m-20 -141.64 140.26 19.93 Favored Pre-proline 0 N--CA 1.477 0.896 0 C-N-CA 123.674 0.79 . . . . 0.0 110.133 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -58.1 -27.0 78.23 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 123.307 2.672 . . . . 0.0 113.409 175.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -65.98 -22.15 66.45 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.168 0.587 . . . . 0.0 111.483 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 69.6 mt -75.96 -44.13 41.34 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.42 0.688 . . . . 0.0 111.2 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 41' ' ' ILE . 9.0 p -67.43 -37.38 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 122.516 0.326 . . . . 0.0 111.026 -179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.1 ptp -76.17 -25.27 55.06 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.375 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -66.5 -17.03 64.57 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.663 0.785 . . . . 0.0 112.128 177.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.8 t80 -58.18 -48.87 78.95 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-O 121.081 0.467 . . . . 0.0 109.808 169.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -91.89 -18.54 23.61 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.574 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.581 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.5 tp10 -86.22 -44.66 11.99 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.362 0.665 . . . . 0.0 111.088 -177.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -85.35 144.54 27.98 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.803 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -71.88 -61.77 1.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 171.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 . . . . . 0 C--O 1.248 0.999 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.779 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 65.09 2.18 1.74 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 173.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.1 t -92.12 94.6 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -87.68 95.05 9.92 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.51 179.74 6.1 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 124.999 1.32 . . . . 0.0 109.456 -175.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.404 HG12 HD13 ' A' ' 46' ' ' LEU . 7.9 p -61.69 149.41 8.88 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 C-N-CA 123.22 0.608 . . . . 0.0 111.455 177.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -60.41 -51.98 67.17 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.534 0.734 . . . . 0.0 109.745 175.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -166.35 142.37 4.78 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.111 174.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.569 HG12 HG12 ' A' ' 23' ' ' VAL . 36.3 mt -79.35 114.03 19.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 165.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.02 -69.34 0.33 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 17.6 ptpt -136.93 164.45 28.3 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.515 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -129.55 157.77 41.12 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.668 174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -153.43 123.44 6.93 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 58.8 t -85.13 115.11 26.36 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.478 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 30.6 ttt180 -142.02 151.55 42.56 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.948 1.299 . . . . 0.0 108.263 -178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.8 ptpt 60.0 23.78 12.92 Favored 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.724 1.609 . . . . 0.0 113.163 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 80.38 2.67 89.58 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-N 116.022 -0.535 . . . . 0.0 113.286 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -121.16 160.3 24.06 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.714 1.606 . . . . 0.0 108.038 -175.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.3 t -97.23 126.19 50.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 171.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -97.99 145.71 26.23 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.46 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.8 m-85 -131.37 109.76 10.57 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.235 0.614 . . . . 0.0 110.644 -172.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 38.9 tp -68.38 106.86 2.65 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.636 0.774 . . . . 0.0 109.169 175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 9' ' ' ILE . 5.0 m -105.55 116.35 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 124.284 1.034 . . . . 0.0 111.569 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -80.33 125.15 29.54 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.502 1.121 . . . . 0.0 108.516 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 78.9 m95 -85.77 144.4 27.77 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.038 0.535 . . . . 0.0 111.295 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -65.43 106.06 1.31 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 123.985 0.914 . . . . 0.0 111.181 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.89 -11.65 64.26 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-N 115.743 -0.662 . . . . 0.0 113.178 177.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 84.9 m95 -103.09 128.65 27.18 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 123.532 0.733 . . . . 0.0 110.214 -175.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -58.08 156.36 29.74 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.12 2.547 . . . . 0.0 112.166 178.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -63.46 -2.26 3.94 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 123.224 2.616 . . . . 0.0 115.359 -172.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -66.26 -27.88 68.28 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 122.12 -0.363 . . . . 0.0 111.133 169.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.46 -17.41 34.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.571 0.748 . . . . 0.0 112.266 178.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 99.8 p -62.9 109.92 1.61 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-O 120.987 0.423 . . . . 0.0 110.597 -175.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 37.2 p -95.67 176.17 6.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.224 1.009 . . . . 0.0 109.647 177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -104.61 116.19 31.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.252 0.621 . . . . 0.0 109.777 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -90.43 137.92 27.21 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 164.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -73.29 172.58 15.32 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 121.76 1.64 . . . . 0.0 111.325 174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' LYS . 3.0 tm-20 -63.22 -23.9 67.63 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.088 0.955 . . . . 0.0 111.354 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.607 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 8.1 pt-20 -78.01 -3.02 39.95 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 177.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.607 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 23.4 m-70 -118.53 9.81 12.4 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 118.532 0.605 . . . . 0.0 112.325 -178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 ' CE1' ' A' ' 21' ' ' TYR . 13.5 mt -70.56 123.29 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.162 0.289 . . . . 0.0 110.601 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -76.14 -25.59 55.47 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -170.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -160.03 145.36 11.36 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 119.595 -0.24 . . . . 0.0 110.867 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -41.12 -42.37 4.79 Favored 'Trans proline' 0 C--N 1.387 2.6 0 C-N-CA 124.861 3.708 . . . . 0.0 114.701 169.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -63.36 -21.68 66.42 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD13 HG12 ' A' ' 6' ' ' VAL . 57.1 mt -79.92 -47.08 15.61 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.436 0.694 . . . . 0.0 111.035 178.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 12.6 p -66.31 -38.99 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.5 ptp -77.86 -16.73 58.06 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.077 177.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.04 -21.24 66.37 Favored 'General case' 0 C--N 1.368 1.38 0 C-N-CA 123.295 0.638 . . . . 0.0 111.5 175.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.424 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 76.2 t80 -60.29 -51.71 68.39 Favored 'General case' 0 CA--C 1.549 0.941 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 168.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -84.82 -12.85 52.71 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.764 0.826 . . . . 0.0 111.993 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -92.03 -50.4 5.72 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.349 0.66 . . . . 0.0 110.399 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -83.14 147.24 28.19 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.266 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.75 5.76 50.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.174 0.99 . . . . 0.0 110.252 175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 124.47 1.108 . . . . 0.0 111.195 -174.468 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -84.5 -12.9 53.35 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.375 0.67 . . . . 0.0 111.715 -173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 56.3 t -94.18 95.56 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -89.81 96.66 10.79 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.716 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -102.68 161.08 14.02 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.213 1.005 . . . . 0.0 109.602 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 46' ' ' LEU . 3.8 p -61.04 146.8 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 122.965 0.506 . . . . 0.0 110.995 -174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -53.49 -66.55 0.37 Allowed 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 124.021 0.929 . . . . 0.0 111.972 -170.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 t -164.46 160.71 20.84 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.518 0.727 . . . . 0.0 109.621 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.532 HG12 HG12 ' A' ' 23' ' ' VAL . 57.3 mt -100.64 120.64 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.02 -58.85 3.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.004 0.922 . . . . 0.0 109.489 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -147.73 161.88 40.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.07 0.548 . . . . 0.0 110.419 -176.808 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -115.43 170.54 8.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.46 0.648 . . . . 0.0 110.723 175.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 45.5 ttt85 -162.6 144.6 10.6 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.212 -1.358 . . . . 0.0 108.4 175.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -109.54 114.81 47.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 168.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.444 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.1 tmm_? -147.02 146.34 30.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.462 1.105 . . . . 0.0 108.169 -172.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 15.4 ptpt 55.58 24.72 7.24 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 126.374 1.869 . . . . 0.0 113.19 -175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.81 27.49 70.64 Favored Glycine 0 C--N 1.35 1.332 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.468 -176.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -135.7 126.02 26.56 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 124.688 1.195 . . . . 0.0 109.672 -176.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -80.11 110.62 15.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 9.7 pt-20 -116.29 151.98 34.77 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.172 0.989 . . . . 0.0 110.167 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.409 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.9 m-85 -128.68 120.29 26.25 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 124.751 1.221 . . . . 0.0 109.728 -172.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 43.7 tp -68.75 105.98 2.5 Favored 'General case' 0 C--N 1.345 0.37 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 HG12 HG12 ' A' ' 9' ' ' ILE . 11.9 m -100.57 158.74 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.887 0.875 . . . . 0.0 111.048 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -106.87 144.26 33.78 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.935 1.294 . . . . 0.0 108.834 178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 38.8 m95 -85.53 148.77 25.79 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.133 0.573 . . . . 0.0 110.016 175.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -71.42 -24.68 62.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.053 0.941 . . . . 0.0 112.607 -174.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -128.73 9.02 6.45 Favored Glycine 0 C--N 1.345 1.056 0 N-CA-C 113.982 0.353 . . . . 0.0 113.982 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.577 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 86.2 m95 -127.53 144.76 52.14 Favored Pre-proline 0 N--CA 1.479 0.975 0 CA-C-N 117.306 0.553 . . . . 0.0 110.9 -172.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -60.59 157.3 37.54 Favored 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 122.836 2.357 . . . . 0.0 112.061 174.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.67 4.49 1.05 Allowed 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 123.588 2.858 . . . . 0.0 114.973 -173.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -72.45 -30.26 64.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.808 0.443 . . . . 0.0 110.902 170.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -83.23 -9.5 59.1 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.18 0.592 . . . . 0.0 111.323 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.2 m -54.26 114.01 1.47 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.728 0.811 . . . . 0.0 111.812 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.1 p -107.76 164.05 12.58 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.173 0.989 . . . . 0.0 110.728 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.449 ' HH2' ' HE3' ' A' ' 11' ' ' LYS . 85.8 m95 -95.97 103.58 15.48 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.354 0.662 . . . . 0.0 109.659 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -99.76 133.89 21.43 Favored Pre-proline 0 N--CA 1.476 0.833 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 170.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 34.9 Cg_endo -64.7 166.88 16.67 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.162 1.908 . . . . 0.0 111.967 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -56.04 -28.25 56.64 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.674 1.19 . . . . 0.0 110.972 -176.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -71.75 -40.24 69.49 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.675 0.79 . . . . 0.0 112.557 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.9 m170 -74.11 -10.05 59.23 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.186 0.594 . . . . 0.0 112.339 -173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.41 129.63 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 123.666 0.604 . . . . 0.0 109.986 -178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -73.15 -24.05 60.53 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.002 -169.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -150.68 121.64 3.86 Favored Pre-proline 0 CA--C 1.55 0.962 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 -169.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.583 ' O ' HG12 ' A' ' 47' ' ' VAL . 14.7 Cg_endo -53.81 -46.15 35.82 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 123.747 2.965 . . . . 0.0 113.864 -173.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -54.85 -17.36 3.49 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.716 HD11 ' HB1' ' A' ' 5' ' ' ALA . 77.6 mt -72.26 -40.02 67.96 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.172 0.589 . . . . 0.0 111.702 175.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.583 HG12 ' O ' ' A' ' 44' ' ' PRO . 6.0 p -64.74 -37.05 79.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 O-C-N 123.365 0.416 . . . . 0.0 110.314 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ptm -78.59 -31.32 47.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.008 0.523 . . . . 0.0 110.357 175.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -65.62 -24.2 67.0 Favored 'General case' 0 C--N 1.366 1.286 0 C-N-CA 123.604 0.762 . . . . 0.0 111.141 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 15.1 t80 -50.72 -51.17 52.37 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 122.968 0.507 . . . . 0.0 110.937 173.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -96.19 -12.19 25.01 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.557 -177.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.7 tp10 -83.97 -36.17 23.41 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.202 0.601 . . . . 0.0 110.369 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.487 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 70.9 mmtt -82.26 161.99 22.48 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.205 0.602 . . . . 0.0 109.989 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.7 tp10 -74.45 -50.05 19.9 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.209 0.603 . . . . 0.0 110.896 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 . . . . . 0 C--O 1.248 0.984 0 C-N-CA 125.198 1.399 . . . . 0.0 109.194 -174.062 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -146.23 -34.06 0.31 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.964 0.506 . . . . 0.0 111.018 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.4 p -83.56 81.97 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.02 0.914 . . . . 0.0 109.526 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -99.21 117.68 34.23 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.625 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.508 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -102.64 -179.72 4.05 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.582 1.153 . . . . 0.0 109.846 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.557 HG12 HD13 ' A' ' 46' ' ' LEU . 13.6 p -58.82 154.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.95 0.9 . . . . 0.0 111.319 176.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -57.81 -56.61 19.71 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 122.944 0.498 . . . . 0.0 110.016 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.5 t -172.25 157.9 4.31 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.098 0.959 . . . . 0.0 109.037 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.5 112.78 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 170.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.76 -52.76 58.96 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.177 0.991 . . . . 0.0 109.663 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.2 ptpt -155.91 161.1 40.6 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.87 177.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -113.51 162.97 15.52 Favored 'General case' 0 C--O 1.242 0.669 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 169.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -171.66 125.1 0.58 Allowed 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -86.22 122.59 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -150.24 144.39 25.57 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.547 1.139 . . . . 0.0 108.142 179.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 5.6 ptpp? 66.36 22.93 10.74 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 126.307 1.843 . . . . 0.0 112.306 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.82 80.06 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.961 -175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -129.57 131.32 46.51 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.267 1.027 . . . . 0.0 108.581 -176.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 11.6 p -77.47 123.03 33.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 CA-C-O 121.286 0.565 . . . . 0.0 109.71 173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -99.34 152.51 19.87 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.954 0.901 . . . . 0.0 109.135 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.76 103.05 5.48 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.4 tp -66.14 106.54 1.67 Allowed 'General case' 0 C--N 1.345 0.398 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 174.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' HB ' HG21 ' A' ' 6' ' ' VAL . 21.6 m -93.38 129.16 44.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 123.523 0.729 . . . . 0.0 110.85 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -77.58 117.46 19.04 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -80.26 139.5 36.65 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -61.89 109.37 1.23 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.138 1.375 . . . . 0.0 111.296 -175.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.25 16.38 74.32 Favored Glycine 0 C--N 1.344 0.976 0 O-C-N 123.644 0.59 . . . . 0.0 113.899 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 97.6 m95 -118.48 138.38 25.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 123.416 0.686 . . . . 0.0 110.272 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -64.69 160.05 42.24 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 123.15 2.567 . . . . 0.0 112.409 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -56.03 -17.74 20.48 Favored 'Trans proline' 0 C--N 1.384 2.41 0 C-N-CA 123.774 2.982 . . . . 0.0 115.55 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -70.25 -34.84 73.31 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.546 0.338 . . . . 0.0 111.623 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -82.81 -15.89 49.9 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.802 0.441 . . . . 0.0 111.519 177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.5 m -64.84 110.17 2.32 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.187 0.595 . . . . 0.0 110.02 177.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.9 p -101.71 161.79 13.39 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.589 0.756 . . . . 0.0 111.157 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 79.6 m95 -88.38 108.34 19.3 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -90.89 125.68 58.16 Favored Pre-proline 0 CA--C 1.545 0.763 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.4 -176.23 1.32 Allowed 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.309 2.006 . . . . 0.0 112.354 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -55.28 -30.59 60.43 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.095 0.958 . . . . 0.0 112.269 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.76 -6.19 54.69 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.539 0.736 . . . . 0.0 112.783 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -107.04 16.58 24.04 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.765 0.426 . . . . 0.0 111.493 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.566 HD13 ' HB ' ' A' ' 47' ' ' VAL . 35.9 mt -74.79 128.06 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 174.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.83 -30.22 62.57 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -157.03 139.48 10.51 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 122.701 0.4 . . . . 0.0 110.195 -175.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -46.41 -32.19 10.71 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 124.591 3.527 . . . . 0.0 114.85 172.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.2 ptm180 -66.87 -24.31 66.11 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.557 HD13 HG12 ' A' ' 6' ' ' VAL . 70.7 mt -76.54 -44.46 34.83 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.353 0.661 . . . . 0.0 111.46 -175.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.566 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -68.14 -35.64 72.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.853 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.0 ptm -76.53 -28.01 56.19 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.462 175.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -62.05 -38.21 87.91 Favored 'General case' 0 C--O 1.203 -1.369 0 C-N-CA 123.571 0.748 . . . . 0.0 110.203 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 91.7 t80 -51.19 -57.61 8.33 Favored 'General case' 0 CA--C 1.549 0.908 0 O-C-N 123.372 0.42 . . . . 0.0 111.161 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -76.47 -11.99 59.97 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.358 0.663 . . . . 0.0 112.295 -177.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -87.46 -34.96 18.51 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.084 0.954 . . . . 0.0 110.547 176.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.7 mmpt? -82.23 -30.47 30.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.488 0.715 . . . . 0.0 110.345 -174.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -132.99 130.14 39.1 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.108 0.48 . . . . 0.0 110.007 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 . . . . . 0 C--O 1.248 1.024 0 C-N-CA 123.823 0.849 . . . . 0.0 109.37 179.155 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 60.1 57.38 3.01 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.918 1.287 . . . . 0.0 110.588 178.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.4 m -94.38 36.07 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.943 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -74.98 93.53 2.71 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.789 0.836 . . . . 0.0 110.341 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.446 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -141.72 -179.69 6.33 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.731 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.608 HG21 ' HB ' ' A' ' 23' ' ' VAL . 9.3 p -62.64 153.52 6.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 C-N-CA 123.464 0.706 . . . . 0.0 111.16 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.521 ' HB2' ' HA ' ' A' ' 26' ' ' LYS . 10.9 tp10 -58.21 -64.19 1.0 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 63.6 m -161.77 154.75 20.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.384 1.074 . . . . 0.0 110.077 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.466 HG12 HG12 ' A' ' 23' ' ' VAL . 69.1 mt -92.1 116.97 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 169.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -72.42 -49.99 29.6 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.22 0.608 . . . . 0.0 109.637 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 21.4 ptmt -157.0 161.9 39.57 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.36 178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -111.88 173.64 6.26 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 168.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -157.36 132.76 9.07 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.901 0.881 . . . . 0.0 109.603 176.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 19' ' ' VAL . 60.9 t -85.82 114.09 25.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 171.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.01 127.27 13.87 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 -166.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.9 ptpt 55.54 26.21 8.8 Favored 'General case' 0 N--CA 1.503 2.19 0 C-N-CA 126.002 1.721 . . . . 0.0 112.741 -176.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.38 20.84 74.18 Favored Glycine 0 C--N 1.35 1.322 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.206 -176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -133.5 124.86 27.73 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.909 1.284 . . . . 0.0 109.354 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.514 HG22 HG22 ' A' ' 14' ' ' VAL . 61.9 t -80.56 109.5 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 176.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 41.4 mt-10 -104.08 138.79 40.08 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.352 1.061 . . . . 0.0 109.743 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.404 ' HD2' HG21 ' A' ' 9' ' ' ILE . 87.5 m-85 -111.28 111.88 23.26 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.691 0.796 . . . . 0.0 109.528 -177.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.8 tp -65.3 105.77 1.2 Allowed 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 172.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.608 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.9 m -103.65 124.13 57.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 124.066 0.946 . . . . 0.0 110.126 -176.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.52 121.31 29.8 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 173.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 82.5 m95 -80.44 145.44 31.94 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.075 0.55 . . . . 0.0 110.221 -175.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.521 ' HA ' ' HB2' ' A' ' 7' ' ' GLU . 49.3 mtmt -52.03 -70.06 0.1 Allowed 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.245 1.018 . . . . 0.0 112.971 -165.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.27 35.38 4.13 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.896 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 87.6 m95 -138.78 137.45 19.88 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 123.923 0.889 . . . . 0.0 109.918 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -63.22 160.99 32.18 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.784 2.323 . . . . 0.0 112.155 171.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -69.43 12.25 0.32 Allowed 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.413 2.742 . . . . 0.0 115.013 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -76.95 -28.64 55.26 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.713 -0.617 . . . . 0.0 109.99 166.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -86.83 -9.9 54.71 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.661 0.784 . . . . 0.0 111.356 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 92.8 p -62.86 107.03 0.9 Allowed 'General case' 0 C--N 1.357 0.894 0 C-N-CA 122.662 0.385 . . . . 0.0 110.362 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 21.2 p -98.6 157.02 16.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.797 0.839 . . . . 0.0 110.479 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 90.8 m95 -84.32 100.29 11.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -97.55 110.42 54.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 22.7 Cg_endo -60.44 176.38 0.85 Allowed 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.733 2.289 . . . . 0.0 113.658 178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.58 -15.75 41.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.485 1.114 . . . . 0.0 113.531 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -84.34 -14.13 50.45 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.777 0.831 . . . . 0.0 112.705 177.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -105.08 8.58 34.32 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 124.016 0.926 . . . . 0.0 111.525 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.581 HD13 ' HB ' ' A' ' 47' ' ' VAL . 10.4 mt -78.48 133.77 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 122.74 0.416 . . . . 0.0 110.39 -178.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.1 -35.99 48.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.014 0.526 . . . . 0.0 111.174 -175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -153.71 140.92 13.32 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -46.86 -31.57 11.15 Favored 'Trans proline' 0 C--N 1.386 2.527 0 C-N-CA 124.503 3.469 . . . . 0.0 114.639 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -61.34 -23.26 65.62 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.075 0.55 . . . . 0.0 112.103 -176.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.517 HD13 HG12 ' A' ' 6' ' ' VAL . 58.5 mt -76.06 -50.75 13.89 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.807 0.843 . . . . 0.0 110.945 -178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.581 ' HB ' HD13 ' A' ' 41' ' ' ILE . 4.4 p -71.48 -38.97 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.156 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 11.8 ptm -71.79 -26.19 62.32 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.748 0.419 . . . . 0.0 110.308 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.82 77.41 Favored 'General case' 0 C--O 1.204 -1.303 0 C-N-CA 123.665 0.786 . . . . 0.0 110.128 171.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 64.9 t80 -71.27 -41.88 69.47 Favored 'General case' 0 CA--C 1.554 1.121 0 O-C-N 121.77 -0.581 . . . . 0.0 110.608 174.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -71.75 -24.95 61.86 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.07 0.548 . . . . 0.0 111.917 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -90.96 -59.43 2.17 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.291 0.636 . . . . 0.0 110.484 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -78.83 122.82 26.55 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.488 0.715 . . . . 0.0 109.538 -173.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -80.96 115.16 20.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.297 0.639 . . . . 0.0 110.207 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.7 mm-40 . . . . . 0 CA--C 1.554 1.127 0 C-N-CA 123.174 0.59 . . . . 0.0 109.717 -179.9 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 120.239 0.066 . . . . 0.0 110.871 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -119.51 -1.33 10.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.309 0.644 . . . . 0.0 112.247 -170.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 46.3 t -87.96 85.11 2.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -95.06 77.88 3.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -89.72 162.56 15.5 Favored 'General case' 0 C--O 1.241 0.647 0 CA-C-N 115.162 -0.926 . . . . 0.0 110.367 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 HG12 HD13 ' A' ' 46' ' ' LEU . 11.5 p -66.35 144.71 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.29 -49.36 78.14 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.2 p -173.24 153.95 2.58 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.268 1.027 . . . . 0.0 108.585 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.507 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.5 mt -87.98 107.26 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 165.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 -45.24 69.22 Favored 'General case' 0 C--O 1.24 0.605 0 O-C-N 123.967 0.792 . . . . 0.0 109.779 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 ptpt -160.21 164.62 32.64 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.768 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -131.68 160.5 35.26 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.441 0.696 . . . . 0.0 109.915 175.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.0 ttt85 -168.34 143.73 3.6 Favored 'General case' 0 C--O 1.242 0.692 0 C-N-CA 123.623 0.769 . . . . 0.0 109.537 176.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 19' ' ' VAL . 69.5 t -87.33 114.7 26.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.803 HH11 ' HB3' ' A' ' 16' ' ' LYS . 1.1 tmt_? -131.49 142.73 50.03 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.832 1.253 . . . . 0.0 107.743 -176.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.803 ' HB3' HH11 ' A' ' 15' ' ' ARG . 54.2 pttt 53.04 25.51 4.15 Favored 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 125.804 1.642 . . . . 0.0 113.909 -177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.38 20.76 76.61 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.959 -0.564 . . . . 0.0 113.038 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -136.68 138.25 40.86 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.144 0.978 . . . . 0.0 109.285 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 14' ' ' VAL . 46.0 t -77.63 112.13 15.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 177.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -104.12 152.06 22.56 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-O 121.535 0.683 . . . . 0.0 109.96 174.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.507 ' HD2' HG21 ' A' ' 9' ' ' ILE . 80.2 m-85 -126.8 121.89 33.22 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 124.715 1.206 . . . . 0.0 108.802 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.1 tp -69.0 104.79 2.2 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 172.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -102.07 114.08 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 124.603 1.161 . . . . 0.0 110.863 -174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -69.46 143.63 53.48 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.869 1.268 . . . . 0.0 110.211 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 90.2 m95 -112.27 135.57 52.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -65.47 -42.68 92.01 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.833 0.853 . . . . 0.0 112.717 -169.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.72 -13.02 61.67 Favored Glycine 0 C--N 1.342 0.892 0 CA-C-N 116.217 -0.447 . . . . 0.0 113.528 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.533 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 49.9 m95 -107.88 147.11 34.81 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 123.559 0.743 . . . . 0.0 110.033 -173.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.35 159.83 48.32 Favored 'Trans proline' 0 CA--C 1.571 2.332 0 C-N-CA 122.505 2.137 . . . . 0.0 111.862 170.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -52.98 -18.56 9.75 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 124.151 3.234 . . . . 0.0 116.14 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -66.95 -24.07 66.03 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 122.981 0.512 . . . . 0.0 112.364 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.41 -1.1 56.19 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.316 0.647 . . . . 0.0 112.048 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.7 t -61.57 118.3 6.87 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.6 p -106.89 151.8 24.76 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.805 0.842 . . . . 0.0 111.51 -171.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -87.0 103.39 15.31 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 172.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -115.96 140.0 25.71 Favored Pre-proline 0 CA--C 1.538 0.519 0 C-N-CA 123.782 0.833 . . . . 0.0 109.899 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.98 -179.86 3.79 Favored 'Trans proline' 0 C--N 1.375 1.957 0 C-N-CA 122.289 1.993 . . . . 0.0 112.785 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -57.65 -29.14 64.35 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.543 1.137 . . . . 0.0 112.397 -175.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.97 -5.32 59.35 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.616 0.766 . . . . 0.0 112.849 -175.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -102.24 3.71 38.52 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.03 0.532 . . . . 0.0 111.074 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.4 mt -79.93 137.2 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -81.02 -32.88 33.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.164 -0.471 . . . . 0.0 112.02 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 8.1 t70 -146.16 140.58 15.61 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.716 0.407 . . . . 0.0 110.081 -171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -48.63 -35.05 28.58 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 124.332 3.355 . . . . 0.0 114.491 172.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -70.21 -26.8 64.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.428 0.291 . . . . 0.0 111.368 -176.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.582 HD13 HG12 ' A' ' 6' ' ' VAL . 82.1 mt -73.87 -40.88 62.91 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.493 0.717 . . . . 0.0 111.231 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.31 -41.71 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 O-C-N 123.2 0.312 . . . . 0.0 110.84 179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 20.6 ptp -72.44 -25.24 61.38 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.463 0.305 . . . . 0.0 110.558 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.651 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -62.98 -22.91 67.16 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 124.056 0.942 . . . . 0.0 112.085 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -51.02 -50.29 58.84 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.094 0.474 . . . . 0.0 110.589 174.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -99.16 -14.82 19.18 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.097 -0.956 . . . . 0.0 112.445 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.651 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 33.3 tt0 -80.0 -36.86 35.32 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.6 0.76 . . . . 0.0 110.455 -179.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 11.1 mmpt? -78.92 169.3 18.43 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.029 0.442 . . . . 0.0 110.646 -178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -128.23 117.6 21.81 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 123.527 0.731 . . . . 0.0 110.281 175.904 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.648 0.261 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -126.54 13.68 7.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.937 0.895 . . . . 0.0 111.478 -178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.8 m -87.97 88.21 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 169.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -76.06 81.54 2.91 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.538 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -140.14 162.25 35.69 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.942 -171.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.524 HG12 HD13 ' A' ' 46' ' ' LEU . 11.4 p -66.61 151.25 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 122.996 0.518 . . . . 0.0 110.974 176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -62.31 -56.8 14.94 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.579 0.751 . . . . 0.0 108.976 173.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.4 m -159.6 141.95 13.59 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.167 0.987 . . . . 0.0 109.588 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.7 mt -83.68 114.23 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 169.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' HD13 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -64.92 -55.75 17.4 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.334 1.054 . . . . 0.0 109.702 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.0 ptpt -155.92 163.27 39.96 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.344 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -110.98 166.23 11.22 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 169.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 tpm_? -160.63 123.31 3.27 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 19' ' ' VAL . 24.1 t -84.32 115.04 25.71 Favored 'Isoleucine or valine' 0 C--N 1.344 0.349 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.45 ' HD2' ' N ' ' A' ' 16' ' ' LYS . 3.5 tmm_? -155.5 152.86 29.41 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -174.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' N ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER 52.69 26.37 4.39 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 125.119 1.368 . . . . 0.0 112.94 -175.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.25 10.07 86.46 Favored Glycine 0 C--N 1.352 1.459 0 CA-C-N 115.199 -0.909 . . . . 0.0 114.448 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -135.96 150.52 49.3 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 117.661 0.73 . . . . 0.0 109.987 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 14' ' ' VAL . 21.6 t -80.27 112.4 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -100.68 145.56 28.28 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.855 0.862 . . . . 0.0 109.271 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -119.71 113.55 20.83 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.764 0.826 . . . . 0.0 109.634 -171.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.477 HD13 ' HD2' ' A' ' 10' ' ' ARG . 3.9 tt -61.94 108.61 1.06 Allowed 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 168.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -114.68 129.57 70.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.406 1.082 . . . . 0.0 110.688 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -85.66 123.99 31.69 Favored 'General case' 0 C--O 1.241 0.634 0 C-N-CA 124.09 0.956 . . . . 0.0 109.491 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.3 m95 -82.24 138.89 34.51 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 123.145 0.578 . . . . 0.0 110.07 177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -62.8 114.08 3.41 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 0.0 111.357 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.27 -2.84 80.25 Favored Glycine 0 CA--C 1.534 1.236 0 O-C-N 123.692 0.62 . . . . 0.0 114.052 174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.454 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 96.9 m95 -97.8 146.96 32.35 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 123.676 0.79 . . . . 0.0 110.224 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.2 151.41 85.56 Favored 'Trans proline' 0 C--N 1.38 2.192 0 C-N-CA 122.719 2.279 . . . . 0.0 112.121 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -52.69 -20.21 12.12 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.037 3.158 . . . . 0.0 115.252 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -65.39 -22.89 66.84 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 118.08 0.4 . . . . 0.0 111.849 177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -96.93 -4.86 39.27 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.582 0.753 . . . . 0.0 112.182 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 97.1 p -63.81 105.13 0.77 Allowed 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.026 0.441 . . . . 0.0 110.16 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.3 p -82.57 174.02 11.43 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.6 0.76 . . . . 0.0 111.931 -173.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -112.17 118.14 34.51 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 12.3 pt-20 -109.82 125.91 30.2 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 123.075 0.55 . . . . 0.0 109.718 175.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HB2' ' HG2' ' A' ' 18' ' ' LYS . 40.5 Cg_endo -66.44 175.9 4.63 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.311 2.008 . . . . 0.0 112.014 175.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 18' ' ' LYS . 44.3 mt-10 -59.72 -19.29 49.06 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 123.973 0.909 . . . . 0.0 113.403 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -85.61 -15.65 41.84 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.511 0.724 . . . . 0.0 112.318 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 47.3 m170 -98.0 -5.41 34.16 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.409 0.684 . . . . 0.0 111.775 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 47' ' ' VAL . 16.6 mt -60.14 127.02 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -175.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -69.43 -28.46 66.15 Favored 'General case' 0 CA--C 1.548 0.884 0 O-C-N 123.774 0.672 . . . . 0.0 111.72 -173.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -165.14 142.58 4.98 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 123.168 0.587 . . . . 0.0 109.553 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -46.6 -28.0 5.92 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 124.421 3.414 . . . . 0.0 114.98 171.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -62.61 -23.55 67.11 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.194 0.598 . . . . 0.0 111.875 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD21 ' HB1' ' A' ' 5' ' ' ALA . 85.5 mt -80.62 -47.72 13.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.046 0.938 . . . . 0.0 111.678 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.53 ' HB ' HD13 ' A' ' 41' ' ' ILE . 10.4 p -63.77 -39.02 83.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 O-C-N 123.297 0.373 . . . . 0.0 110.489 -178.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptm -69.43 -39.67 77.72 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 176.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -58.82 -35.67 73.26 Favored 'General case' 0 C--N 1.367 1.364 0 C-N-CA 123.986 0.915 . . . . 0.0 111.279 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 46.2 t80 -54.91 -45.4 74.75 Favored 'General case' 0 CA--C 1.553 1.058 0 O-C-N 123.422 0.451 . . . . 0.0 111.144 177.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -97.41 -8.54 29.19 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.023 0.529 . . . . 0.0 111.831 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -89.41 -43.73 10.67 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.732 0.813 . . . . 0.0 110.526 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -89.15 153.35 21.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.161 0.985 . . . . 0.0 109.376 -174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -68.86 -43.88 74.46 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.452 0.701 . . . . 0.0 111.288 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 . . . . . 0 C--O 1.253 1.279 0 C-N-CA 123.96 0.904 . . . . 0.0 108.701 176.4 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -77.91 77.1 4.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.382 0.673 . . . . 0.0 109.927 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.5 p -166.34 79.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.914 1.286 . . . . 0.0 108.259 172.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -81.55 84.12 6.83 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.921 -1.036 . . . . 0.0 108.568 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.579 ' HB1' HD11 ' A' ' 46' ' ' LEU . . . -121.97 178.14 5.01 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 114.136 -1.393 . . . . 0.0 109.9 -178.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 9.8 p -67.15 152.49 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.48 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 24' ' ' LYS . 33.5 tt0 -60.35 -53.36 58.52 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.8 t -174.53 165.29 3.84 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.526 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.49 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.5 mt -95.38 112.93 28.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.522 HH11 ' HE3' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -61.61 -51.14 69.73 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.425 1.078 . . . . 0.0 109.126 -178.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE3' HH11 ' A' ' 10' ' ' ARG . 16.4 ptpt -158.89 158.41 33.34 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.875 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -118.51 157.17 27.79 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.3 ttt85 -163.04 135.41 5.36 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.679 178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 55.1 t -85.19 115.03 26.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 2.0 tmt_? -145.72 143.88 30.02 Favored 'General case' 0 C--O 1.218 -0.567 0 C-N-CA 124.809 1.244 . . . . 0.0 108.07 -169.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' ARG . 57.9 pttt 54.61 22.57 4.09 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 125.933 1.693 . . . . 0.0 113.178 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 75.77 22.1 75.41 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 116.44 -0.345 . . . . 0.0 113.529 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -137.25 132.39 33.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.063 0.945 . . . . 0.0 109.896 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 14.2 t -80.55 109.81 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 42.2 mt-10 -119.91 152.36 37.5 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.619 0.768 . . . . 0.0 110.435 -175.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.49 ' HD2' HG21 ' A' ' 9' ' ' ILE . 30.1 m-85 -129.33 116.5 19.18 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.94 0.896 . . . . 0.0 109.931 -168.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -65.19 106.54 1.34 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 174.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' HG21 ' A' ' 6' ' ' VAL . 4.7 m -96.21 113.13 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 123.87 0.868 . . . . 0.0 111.664 -173.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HG2' ' HB2' ' A' ' 10' ' ' ARG . 10.7 mmmm -71.53 114.08 9.23 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.011 169.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 50.2 m95 -76.33 154.4 35.06 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 173.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 36.6 mtmm -67.36 101.16 0.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.332 0.653 . . . . 0.0 111.379 -172.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.78 8.74 82.26 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.127 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 45.4 m95 -102.53 127.67 29.86 Favored Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 122.937 0.495 . . . . 0.0 110.04 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.64 152.16 50.35 Favored 'Trans proline' 0 C--N 1.378 2.127 0 C-N-CA 122.804 2.336 . . . . 0.0 112.043 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -62.55 -3.52 4.44 Favored 'Trans proline' 0 C--N 1.381 2.282 0 C-N-CA 123.384 2.722 . . . . 0.0 115.329 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -65.69 -35.63 81.33 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 122.948 0.499 . . . . 0.0 111.174 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -84.1 -18.38 37.06 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.838 0.855 . . . . 0.0 111.099 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 m -62.42 120.09 10.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.363 0.665 . . . . 0.0 111.53 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p -101.36 169.31 8.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.899 0.879 . . . . 0.0 109.688 177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 77.9 m95 -96.6 101.74 13.4 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -95.09 125.27 51.18 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.462 0.705 . . . . 0.0 110.224 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 57.7 Cg_endo -67.25 179.39 2.44 Favored 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 122.495 2.13 . . . . 0.0 112.686 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -61.27 -27.34 68.39 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.6 0.76 . . . . 0.0 112.37 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.36 -21.77 58.07 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.388 0.675 . . . . 0.0 112.442 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -95.79 6.76 48.12 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.085 0.554 . . . . 0.0 112.009 -176.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.1 mt -81.19 137.46 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -82.96 -26.92 30.9 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 122.836 0.454 . . . . 0.0 111.595 -170.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -159.26 144.97 11.96 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 122.94 0.496 . . . . 0.0 110.177 -174.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -49.41 -28.19 15.24 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 124.558 3.505 . . . . 0.0 114.825 172.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.6 ptm85 -66.48 -27.73 68.03 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.972 0.509 . . . . 0.0 111.479 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 46.6 mt -79.71 -43.46 22.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.714 0.806 . . . . 0.0 110.963 -174.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.2 p -65.58 -39.33 84.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 O-C-N 123.211 0.319 . . . . 0.0 110.468 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.5 ptm -76.68 -26.0 54.28 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.607 177.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -56.85 -29.07 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 124.136 0.975 . . . . 0.0 112.475 -178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.431 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 55.4 t80 -51.49 -50.87 59.04 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.852 0.861 . . . . 0.0 111.309 175.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -99.52 -21.65 15.83 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.143 0.977 . . . . 0.0 112.333 -175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.22 -52.02 5.64 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 123.227 0.611 . . . . 0.0 110.32 -169.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.1 mmpt? -70.45 169.65 13.62 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.065 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 67.37 93.7 0.07 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.179 1.392 . . . . 0.0 110.692 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.152 0.981 . . . . 0.0 109.424 176.024 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.458 0.17 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 56.75 46.39 20.08 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.619 1.168 . . . . 0.0 111.392 173.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 t -91.01 63.83 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 122.064 0.935 . . . . 0.0 108.704 -175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -128.72 126.3 39.75 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.835 175.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.05 179.63 6.62 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 124.181 0.992 . . . . 0.0 108.904 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.527 HG12 HD13 ' A' ' 46' ' ' LEU . 11.8 p -65.76 149.26 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.866 0.467 . . . . 0.0 110.192 172.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.3 -49.81 68.09 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.1 p -170.01 148.46 3.44 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.597 0.759 . . . . 0.0 109.605 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 HG21 ' HD2' ' A' ' 21' ' ' TYR . 52.5 mt -88.35 117.15 31.42 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.32 -53.11 9.3 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 123.916 0.76 . . . . 0.0 109.828 -173.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 18.5 ptpt -151.23 164.24 37.03 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.357 0.663 . . . . 0.0 111.049 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.02 165.21 17.85 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 171.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 tpt180 -160.03 141.24 12.45 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.624 1.17 . . . . 0.0 108.829 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 19' ' ' VAL . 38.7 t -87.12 112.01 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 170.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.9 tpt180 -119.1 134.74 55.02 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.5 pttm 52.2 26.21 3.8 Favored 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 125.611 1.564 . . . . 0.0 113.28 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 76.92 27.28 60.74 Favored Glycine 0 C--N 1.351 1.364 0 CA-C-N 116.118 -0.492 . . . . 0.0 113.265 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.7 tptt -136.25 117.04 14.06 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.488 1.115 . . . . 0.0 108.814 -175.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.554 HG22 HG22 ' A' ' 14' ' ' VAL . 47.7 t -72.39 112.27 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 43.6 mt-10 -118.21 148.73 42.09 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.984 0.914 . . . . 0.0 110.555 -177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.483 ' HD2' HG21 ' A' ' 9' ' ' ILE . 44.8 m-85 -123.64 123.46 40.62 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.931 1.292 . . . . 0.0 109.683 -172.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.48 108.46 4.89 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.398 1.079 . . . . 0.0 110.261 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.461 HG12 HG12 ' A' ' 9' ' ' ILE . 6.6 m -99.21 114.96 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 123.572 0.749 . . . . 0.0 111.575 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.42 118.33 29.0 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 174.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 69.8 m95 -80.06 157.05 26.82 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.613 0.765 . . . . 0.0 112.111 -172.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt -63.26 -66.2 0.58 Allowed 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.882 0.873 . . . . 0.0 111.999 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.26 10.44 71.21 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.354 -176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.699 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -127.13 135.59 27.62 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 122.916 0.486 . . . . 0.0 110.932 -175.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.558 ' HG2' ' HG2' ' A' ' 31' ' ' LYS . 56.2 Cg_endo -67.93 167.22 22.11 Favored 'Trans proline' 0 CA--C 1.565 2.034 0 C-N-CA 123.248 2.632 . . . . 0.0 113.02 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 77.3 Cg_exo -54.97 -12.16 4.56 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 123.97 3.114 . . . . 0.0 116.384 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 19.4 ptpt -67.41 -24.68 65.69 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 117.93 0.332 . . . . 0.0 111.554 173.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -88.64 -12.3 42.9 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.419 1.088 . . . . 0.0 111.583 176.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.405 ' OG ' ' HA ' ' A' ' 30' ' ' PRO . 53.8 m -61.41 103.88 0.35 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.052 0.454 . . . . 0.0 111.175 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 22.1 p -102.19 153.57 19.83 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.128 0.971 . . . . 0.0 110.942 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -85.74 113.21 21.74 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -115.79 134.9 22.63 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 174.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.56 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 36.6 Cg_endo -62.73 167.1 12.39 Favored 'Trans proline' 0 C--N 1.373 1.855 0 C-N-CA 122.216 1.944 . . . . 0.0 111.992 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -55.35 -24.82 31.35 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.7 1.2 . . . . 0.0 111.498 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -74.57 -33.89 62.79 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.408 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 0.5 OUTLIER -74.8 -15.27 60.75 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.676 0.39 . . . . 0.0 111.696 -177.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.6 mt -69.63 132.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.946 0.498 . . . . 0.0 109.961 -176.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -70.46 -51.86 26.23 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -169.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 7.6 t70 -127.5 142.78 45.12 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 122.784 0.434 . . . . 0.0 109.958 -172.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -49.79 -27.38 15.39 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 124.181 3.254 . . . . 0.0 114.751 172.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -67.9 -28.39 67.47 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.747 0.419 . . . . 0.0 111.349 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.527 HD13 HG12 ' A' ' 6' ' ' VAL . 70.9 mt -78.34 -45.27 23.01 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.167 0.587 . . . . 0.0 110.52 -175.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.8 p -64.91 -37.86 81.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 122.684 0.394 . . . . 0.0 111.254 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.2 ptm -76.7 -25.68 53.88 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.657 0.383 . . . . 0.0 111.403 179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -58.58 -32.99 69.47 Favored 'General case' 0 C--N 1.364 1.206 0 C-N-CA 124.22 1.008 . . . . 0.0 111.73 -177.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 7.3 t80 -53.69 -53.65 49.0 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 120.783 0.325 . . . . 0.0 110.916 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.36 -24.3 32.11 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.312 0.645 . . . . 0.0 111.718 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -75.84 -36.47 59.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.449 0.7 . . . . 0.0 110.621 -179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 10.2 mmpt? -81.92 -44.49 16.71 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.088 0.555 . . . . 0.0 109.676 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 61.83 98.58 0.03 OUTLIER 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.392 1.077 . . . . 0.0 111.609 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.483 1.181 0 C-N-CA 123.403 0.681 . . . . 0.0 111.059 -175.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 67.63 -3.24 1.15 Allowed 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 125.218 1.407 . . . . 0.0 113.375 178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.1 m -94.3 58.0 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.162 0.985 . . . . 0.0 109.572 -178.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -76.59 85.15 3.27 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.077 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.5 178.29 5.48 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 113.967 -1.469 . . . . 0.0 110.159 -174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.58 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.98 153.8 8.45 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 123.101 0.56 . . . . 0.0 110.825 173.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -54.79 -57.03 13.2 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.797 0.839 . . . . 0.0 108.956 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.401 ' H ' HG22 ' A' ' 6' ' ' VAL . 35.3 t -168.08 148.92 5.05 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.94 0.896 . . . . 0.0 108.892 177.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.8 mt -76.68 115.22 18.04 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 168.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -69.28 0.31 Allowed 'General case' 0 C--N 1.343 0.326 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 22.4 ptmt -148.5 150.3 33.17 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -171.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -122.18 160.47 25.1 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-O 120.855 0.359 . . . . 0.0 110.404 177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -157.71 141.08 15.41 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 109.757 172.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 19' ' ' VAL . 22.6 t -86.02 114.85 26.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 175.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HD3' ' HG2' ' A' ' 16' ' ' LYS . 1.8 tmt_? -135.67 128.89 31.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.731 1.212 . . . . 0.0 108.18 -173.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HG2' ' HD3' ' A' ' 15' ' ' ARG . 20.7 ptmt 52.73 26.67 4.64 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 126.489 1.916 . . . . 0.0 113.349 -175.103 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.86 -1.53 87.94 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.881 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -106.57 117.92 35.31 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.585 1.154 . . . . 0.0 109.0 -179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.493 HG22 HG22 ' A' ' 14' ' ' VAL . 13.8 t -78.95 110.29 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.52 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 51.3 mt-10 -101.09 142.99 31.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.63 0.772 . . . . 0.0 109.705 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -122.56 105.85 10.48 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.25 1.02 . . . . 0.0 109.145 -175.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.09 105.13 0.44 Allowed 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.58 ' HB ' HG21 ' A' ' 6' ' ' VAL . 15.4 m -93.2 117.77 37.4 Favored 'Isoleucine or valine' 0 C--O 1.241 0.615 0 C-N-CA 123.075 0.55 . . . . 0.0 109.781 -179.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.449 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -77.09 104.22 7.47 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.7 m95 -65.48 149.3 50.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.78 0.432 . . . . 0.0 111.852 -175.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -68.65 111.51 4.84 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.948 0.899 . . . . 0.0 110.845 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.17 -27.65 12.75 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 116.125 -0.488 . . . . 0.0 112.655 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 85.8 m95 -89.92 128.31 50.54 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.473 0.709 . . . . 0.0 110.219 -177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.24 160.57 30.24 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.84 2.36 . . . . 0.0 112.232 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.414 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 87.3 Cg_exo -50.25 -12.79 0.53 Allowed 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 124.582 3.522 . . . . 0.0 116.597 -178.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -73.31 -38.68 65.76 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.022 0.529 . . . . 0.0 111.797 175.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -81.36 -13.05 58.76 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.199 0.6 . . . . 0.0 111.373 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 24' ' ' LYS . 39.5 m -62.86 138.27 58.49 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.753 0.821 . . . . 0.0 111.117 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.9 p -120.2 146.43 46.03 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.466 0.706 . . . . 0.0 110.457 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 74.5 m95 -75.7 101.2 4.92 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 32.9 mm-40 -98.59 119.91 60.31 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.5 176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 46.6 Cg_endo -64.75 -174.47 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.982 2.455 . . . . 0.0 113.813 -177.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -57.09 -30.94 64.75 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.507 1.123 . . . . 0.0 112.399 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -84.82 -8.7 58.7 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.132 0.973 . . . . 0.0 112.276 -178.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 30.1 m170 -113.38 25.34 11.39 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.137 0.975 . . . . 0.0 110.578 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.5 mt -91.78 137.76 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 170.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -80.88 -23.39 39.06 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -164.09 142.56 5.9 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 122.711 0.404 . . . . 0.0 110.554 -176.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.45 ' O ' HG12 ' A' ' 47' ' ' VAL . 3.4 Cg_exo -42.44 -42.37 7.98 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 125.188 3.926 . . . . 0.0 115.435 170.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -66.91 -21.14 66.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.116 0.567 . . . . 0.0 111.837 -172.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.579 HD13 HG12 ' A' ' 6' ' ' VAL . 29.6 mt -75.67 -44.43 42.43 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.422 0.689 . . . . 0.0 110.705 -178.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 44' ' ' PRO . 14.9 p -70.25 -32.94 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.222 -176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.2 ptt? -74.45 -37.44 63.25 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.561 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -64.7 -21.95 66.86 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 124.093 0.957 . . . . 0.0 111.62 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.501 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 50.0 t80 -56.38 -62.32 1.8 Allowed 'General case' 0 CA--C 1.552 1.046 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 171.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -86.07 -4.57 59.2 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.256 0.622 . . . . 0.0 112.287 -177.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.561 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.8 tp10 -85.09 -42.91 14.36 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.897 0.479 . . . . 0.0 110.001 176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 69.8 mmtt -87.21 153.75 21.25 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.954 -177.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -73.47 -33.74 65.01 Favored 'General case' 0 C--O 1.243 0.714 0 C-N-CA 123.884 0.873 . . . . 0.0 111.414 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.249 1.074 0 C-N-CA 123.604 0.762 . . . . 0.0 110.634 -175.585 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 72.08 -8.29 1.17 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 126.102 1.761 . . . . 0.0 113.763 174.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -86.95 71.78 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.82 0.819 . . . . 0.0 108.814 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -94.45 93.11 7.47 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.422 177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.79 -177.58 3.82 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.445 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.2 p -52.7 149.5 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.045 0.938 . . . . 0.0 112.746 178.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -57.34 -58.15 9.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 174.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.2 m -166.97 142.54 4.24 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.337 1.455 . . . . 0.0 108.223 177.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 23' ' ' VAL . 55.8 mt -78.33 115.74 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 168.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.95 -48.67 65.24 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.818 0.847 . . . . 0.0 109.391 -176.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 18.1 ptpt -155.32 163.11 40.57 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.579 0.549 . . . . 0.0 110.88 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.13 164.73 14.33 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 170.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.8 ttt180 -167.56 141.48 3.57 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.765 0.826 . . . . 0.0 109.894 -178.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 19' ' ' VAL . 40.8 t -87.76 114.99 27.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 169.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.24 136.38 22.43 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 -169.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? 55.01 25.18 6.64 Favored 'General case' 0 N--CA 1.504 2.235 0 C-N-CA 125.892 1.677 . . . . 0.0 112.501 -172.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.28 20.51 79.62 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.58 -0.737 . . . . 0.0 113.412 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -135.86 129.01 31.7 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.574 1.15 . . . . 0.0 109.083 -174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 14' ' ' VAL . 40.0 t -75.27 106.75 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 45.3 mt-10 -103.22 156.87 17.4 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.733 1.213 . . . . 0.0 110.276 178.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HD2' HG21 ' A' ' 9' ' ' ILE . 90.7 m-85 -129.17 111.36 12.83 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.573 1.149 . . . . 0.0 109.361 -173.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 33' ' ' SER . 58.1 tp -67.1 106.37 1.96 Allowed 'General case' 0 C--N 1.347 0.467 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 172.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 9' ' ' ILE . 16.1 m -101.05 153.69 4.79 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.979 0.912 . . . . 0.0 111.381 -177.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -107.87 129.1 55.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 109.144 175.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 55.9 m95 -88.09 142.37 27.82 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.097 0.559 . . . . 0.0 110.251 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -70.79 102.26 2.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.017 0.927 . . . . 0.0 111.007 -174.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.37 -9.46 76.05 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.978 -0.555 . . . . 0.0 113.79 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.541 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 22.5 m95 -86.23 129.75 52.45 Favored Pre-proline 0 N--CA 1.476 0.86 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -57.59 155.39 31.62 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.861 2.374 . . . . 0.0 111.945 178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.84 2.97 1.72 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.376 2.717 . . . . 0.0 115.063 -172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.7 -24.58 65.41 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.964 0.506 . . . . 0.0 110.661 167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -92.67 16.61 11.8 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.641 1.176 . . . . 0.0 112.214 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.539 ' HB2' HD11 ' A' ' 22' ' ' LEU . 51.2 p -69.33 100.06 1.29 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.087 0.555 . . . . 0.0 110.524 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 42.8 p -101.97 160.32 14.59 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.61 0.764 . . . . 0.0 111.259 -176.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 68.6 m95 -108.13 131.57 54.5 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.235 1.014 . . . . 0.0 108.936 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HB2' ' HB2' ' A' ' 40' ' ' HIS . 9.6 pt-20 -131.12 129.69 22.54 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 123.635 0.774 . . . . 0.0 109.581 173.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 56.9 Cg_endo -68.21 177.55 4.39 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.413 2.075 . . . . 0.0 113.756 177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -48.13 -34.36 9.72 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 125.684 1.594 . . . . 0.0 112.937 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -85.75 -3.9 59.02 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.781 0.832 . . . . 0.0 113.123 -173.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 36' ' ' GLU . 3.0 m-70 -110.46 -2.59 16.48 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 111.405 177.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.56 137.68 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 O-C-N 123.433 0.458 . . . . 0.0 109.982 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.69 -29.35 58.98 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.4 0.28 . . . . 0.0 111.537 -177.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -162.6 143.78 7.82 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 122.441 0.297 . . . . 0.0 110.328 178.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -48.8 -20.66 3.0 Favored 'Trans proline' 0 C--N 1.384 2.397 0 C-N-CA 124.639 3.56 . . . . 0.0 115.46 172.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.403 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 3.8 ptm85 -67.71 -19.88 65.21 Favored 'General case' 0 N--CA 1.478 0.933 0 O-C-N 122.152 -0.343 . . . . 0.0 111.254 179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -80.55 -39.12 28.32 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.708 0.803 . . . . 0.0 111.91 -176.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 p -68.3 -39.15 80.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.403 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 24.4 ptm -74.2 -20.78 60.08 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.644 176.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.4 -26.75 66.6 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.134 0.574 . . . . 0.0 111.263 175.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 11' ' ' LYS . 11.4 t80 -81.74 -69.85 0.58 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 170.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -77.22 -52.21 9.62 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 -164.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -64.46 -27.72 69.18 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.531 0.333 . . . . 0.0 111.226 -176.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.3 mmtp -92.22 2.48 56.58 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 111.929 0.344 . . . . 0.0 111.929 -179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.89 98.41 4.15 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.176 0.591 . . . . 0.0 110.334 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 . . . . . 0 CA--C 1.562 1.414 0 C-N-CA 125.263 1.425 . . . . 0.0 112.136 173.527 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 N--CA 1.483 1.176 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 75.44 -42.18 0.47 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.874 1.669 . . . . 0.0 115.141 166.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.0 p -94.15 124.71 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 123.705 0.802 . . . . 0.0 109.313 -175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -123.15 70.78 1.03 Allowed 'General case' 0 C--O 1.243 0.741 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 174.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -80.39 -179.67 7.25 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.164 -176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.8 p -62.65 144.39 14.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 168.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -66.9 -49.94 63.99 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.381 0.272 . . . . 0.0 111.024 -175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.9 t -167.78 179.92 4.55 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.433 -175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 47' ' ' VAL . 45.9 mt -112.46 119.68 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.61 -49.6 62.24 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 19.8 ptmt -162.33 162.07 27.79 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 123.604 0.565 . . . . 0.0 111.289 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.36 152.46 47.45 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.999 0.428 . . . . 0.0 110.064 177.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.414 ' HA ' ' NE ' ' A' ' 13' ' ' ARG . 1.0 OUTLIER -156.34 144.1 19.42 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.645 1.178 . . . . 0.0 108.105 173.373 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 19' ' ' VAL . 58.0 t -86.24 116.25 28.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.4 tpp85 -108.61 127.84 54.31 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.955 1.302 . . . . 0.0 109.761 177.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.0 pttt 53.2 26.02 4.76 Favored 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 126.152 1.781 . . . . 0.0 114.396 172.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.77 21.88 41.5 Favored Glycine 0 C--N 1.35 1.336 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.954 179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.35 133.28 34.7 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.278 1.031 . . . . 0.0 109.133 175.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.479 HG22 HG22 ' A' ' 14' ' ' VAL . 17.0 t -74.51 114.55 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.69 144.77 26.99 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.058 1.343 . . . . 0.0 108.352 -178.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -129.79 106.29 8.59 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.795 0.838 . . . . 0.0 110.134 -173.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 25.5 tp -63.65 105.52 0.81 Allowed 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' HG21 ' A' ' 6' ' ' VAL . 10.1 m -80.0 159.91 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.814 0.845 . . . . 0.0 111.975 -176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -127.16 113.56 16.54 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 173.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 70.3 m95 -81.46 151.28 27.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.048 0.539 . . . . 0.0 111.219 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -66.88 107.33 2.17 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.289 0.636 . . . . 0.0 110.95 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.11 16.19 80.07 Favored Glycine 0 CA--C 1.531 1.055 0 O-C-N 123.488 0.492 . . . . 0.0 113.673 176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.5 m95 -110.24 141.72 24.48 Favored Pre-proline 0 N--CA 1.48 1.035 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 35.8 Cg_endo -63.43 144.72 91.38 Favored 'Trans proline' 0 C--N 1.374 1.904 0 C-N-CA 122.442 2.095 . . . . 0.0 111.598 176.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 29' ' ' PRO . 17.3 Cg_exo -68.71 20.61 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.952 3.101 . . . . 0.0 114.884 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -82.11 -33.48 29.71 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 122.016 -0.427 . . . . 0.0 110.221 166.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -83.58 5.55 23.82 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.867 0.867 . . . . 0.0 111.441 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 78.4 p -65.13 118.66 9.53 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.23 1.012 . . . . 0.0 110.101 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.405 ' O ' HG22 ' A' ' 23' ' ' VAL . 22.8 p -113.91 147.72 38.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.077 0.951 . . . . 0.0 110.646 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -82.57 102.14 11.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.258 0.623 . . . . 0.0 109.429 178.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -105.88 130.36 23.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.974 1.31 . . . . 0.0 110.648 -174.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HD2' ' ND1' ' A' ' 40' ' ' HIS . 50.4 Cg_endo -66.39 178.27 2.7 Favored 'Trans proline' 0 C--N 1.376 1.979 0 C-N-CA 122.762 2.308 . . . . 0.0 113.864 -177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -59.34 -23.56 62.62 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.486 1.114 . . . . 0.0 112.751 -177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.0 -33.35 39.4 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.229 0.612 . . . . 0.0 111.213 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.438 ' ND1' ' HD2' ' A' ' 37' ' ' PRO . 46.7 m170 -80.79 8.89 7.15 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.115 0.566 . . . . 0.0 111.846 -176.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.653 HD13 ' HB ' ' A' ' 47' ' ' VAL . 19.8 mt -76.33 130.28 36.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 170.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD23 HG12 ' A' ' 6' ' ' VAL . 3.5 mm? -88.33 -20.3 25.54 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.532 0.333 . . . . 0.0 111.771 -175.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.415 ' H ' HD12 ' A' ' 46' ' ' LEU . 8.4 t70 -160.28 138.97 7.68 Favored Pre-proline 0 N--CA 1.478 0.927 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -175.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -47.89 -32.35 17.36 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 124.162 3.241 . . . . 0.0 114.118 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.9 ptm180 -59.56 -28.57 67.24 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.736 0.814 . . . . 0.0 111.754 -177.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.415 HD12 ' H ' ' A' ' 43' ' ' ASP . 40.5 mt -75.09 -53.33 9.06 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.338 1.055 . . . . 0.0 111.351 -173.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.653 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.6 p -60.85 -42.7 93.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 O-C-N 123.627 0.58 . . . . 0.0 111.348 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.1 ptp -71.4 -34.8 70.71 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.491 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.27 -32.47 73.88 Favored 'General case' 0 C--N 1.366 1.287 0 C-N-CA 123.789 0.836 . . . . 0.0 112.383 -176.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 11.2 t80 -61.33 -52.1 66.08 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 118.535 0.607 . . . . 0.0 110.088 176.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -91.53 -7.07 51.4 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -171.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.5 -43.09 10.47 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 174.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -98.97 167.47 10.71 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.44 1.096 . . . . 0.0 109.778 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -97.94 -81.75 0.43 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.579 0.352 . . . . 0.0 110.289 -175.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 . . . . . 0 C--O 1.252 1.19 0 C-N-CA 124.363 1.065 . . . . 0.0 109.149 -178.109 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 67.56 3.08 3.21 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 125.466 1.506 . . . . 0.0 113.269 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.8 t -88.74 90.36 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -100.61 95.85 6.96 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.784 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.37 163.09 28.36 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.216 0.606 . . . . 0.0 110.194 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.604 HG12 HD13 ' A' ' 46' ' ' LEU . 10.7 p -67.0 142.89 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 122.286 0.235 . . . . 0.0 110.755 -179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -63.27 -44.74 94.26 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.525 0.73 . . . . 0.0 110.927 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' H ' HG22 ' A' ' 6' ' ' VAL . 51.3 p -162.58 132.96 4.68 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 123.509 0.724 . . . . 0.0 109.651 -175.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.414 HG21 ' HD2' ' A' ' 21' ' ' TYR . 63.5 mt -82.52 115.05 24.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 165.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -53.21 29.65 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 124.07 0.856 . . . . 0.0 109.542 -176.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.585 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.0 ptmt -162.09 161.28 28.16 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.238 0.615 . . . . 0.0 110.435 -179.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -109.15 166.81 10.57 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.677 0.391 . . . . 0.0 110.027 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -157.05 136.28 11.98 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 124.477 1.111 . . . . 0.0 109.069 176.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.93 115.07 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.76 142.63 26.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -169.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? 50.24 31.03 4.78 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 125.521 1.528 . . . . 0.0 113.223 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.68 27.65 73.58 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.359 -0.837 . . . . 0.0 113.093 -177.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.82 137.19 37.92 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.21 1.004 . . . . 0.0 110.692 -175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 14' ' ' VAL . 45.7 t -83.05 110.66 18.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 173.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 40.0 mt-10 -116.19 153.11 32.43 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.286 1.034 . . . . 0.0 110.285 -178.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.48 ' HE1' ' HG2' ' A' ' 38' ' ' GLU . 35.2 m-85 -126.15 116.74 21.81 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.124 0.969 . . . . 0.0 109.837 -170.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 36.1 tp -64.66 103.82 0.73 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 173.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.1 m -98.24 125.79 51.44 Favored 'Isoleucine or valine' 0 C--O 1.243 0.727 0 C-N-CA 124.113 0.965 . . . . 0.0 109.628 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -78.67 117.5 19.88 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 98.2 m95 -72.39 140.43 48.4 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -62.87 -40.76 98.49 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.139 0.975 . . . . 0.0 113.046 -169.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.88 5.4 36.74 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.242 -0.435 . . . . 0.0 113.296 -177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 69.6 m95 -126.8 139.08 33.97 Favored Pre-proline 0 N--CA 1.486 1.353 0 CA-C-N 117.635 0.718 . . . . 0.0 110.749 -173.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.88 158.07 40.09 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 123.06 2.507 . . . . 0.0 113.013 -177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' HA ' ' OG ' ' A' ' 33' ' ' SER . 35.9 Cg_exo -60.0 -15.77 35.19 Favored 'Trans proline' 0 C--N 1.388 2.622 0 C-N-CA 123.746 2.964 . . . . 0.0 114.781 -174.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -67.47 -36.06 80.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.711 0.404 . . . . 0.0 111.345 175.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -94.38 6.87 47.41 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.4 0.68 . . . . 0.0 111.756 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' HD1' ' A' ' 25' ' ' TRP . 63.5 m -63.77 133.98 54.46 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 171.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -112.95 155.11 25.33 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.554 0.742 . . . . 0.0 110.84 -174.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -88.73 133.06 34.35 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -131.68 136.39 28.37 Favored Pre-proline 0 N--CA 1.473 0.696 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 174.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 54.5 Cg_endo -66.75 174.36 6.71 Favored 'Trans proline' 0 C--N 1.374 1.909 0 C-N-CA 122.544 2.162 . . . . 0.0 112.849 -176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.48 ' HG2' ' HE1' ' A' ' 21' ' ' TYR . 46.9 mt-10 -61.36 -19.42 61.84 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 123.487 0.715 . . . . 0.0 112.157 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.42 ' HG3' ' HD2' ' A' ' 40' ' ' HIS . 11.5 pt-20 -88.46 -13.26 40.8 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.126 0.97 . . . . 0.0 112.55 -178.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.42 ' HD2' ' HG3' ' A' ' 39' ' ' GLU . 9.4 m170 -95.25 -14.26 24.17 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 123.007 0.523 . . . . 0.0 111.866 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.36 130.45 25.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 O-C-N 123.723 0.64 . . . . 0.0 111.142 -169.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -67.98 -23.4 65.02 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.815 0.697 . . . . 0.0 112.416 -169.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -162.92 143.35 7.3 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.74 -29.08 40.61 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.688 2.925 . . . . 0.0 114.324 172.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -69.28 -18.0 63.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.762 0.425 . . . . 0.0 112.065 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.604 HD13 HG12 ' A' ' 6' ' ' VAL . 55.9 mt -79.55 -51.6 9.1 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.677 0.791 . . . . 0.0 110.874 -178.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.6 -34.94 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.178 0.591 . . . . 0.0 111.325 -178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.3 ptm -73.81 -38.09 64.7 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-O 119.122 -0.466 . . . . 0.0 109.78 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.464 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -65.36 -27.11 68.34 Favored 'General case' 0 C--N 1.367 1.354 0 C-N-CA 123.613 0.765 . . . . 0.0 111.115 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 42.5 t80 -56.15 -52.23 65.11 Favored 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 120.869 0.366 . . . . 0.0 110.465 173.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -95.94 -2.74 46.49 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.893 0.877 . . . . 0.0 112.454 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.464 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.3 tp10 -88.86 -42.67 11.72 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.641 0.776 . . . . 0.0 109.444 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -90.4 168.44 11.86 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.307 -172.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -111.82 58.14 0.63 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 108.564 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.257 1.472 0 C-N-CA 124.632 1.173 . . . . 0.0 109.687 -175.02 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 . . . . . 0 N--CA 1.484 1.237 0 N-CA-C 108.625 -0.879 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 -104.61 25.57 10.13 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.008 0.923 . . . . 0.0 110.819 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.6 m -87.44 72.27 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 121.854 0.835 . . . . 0.0 110.931 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -82.78 86.46 6.89 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.756 0.789 . . . . 0.0 108.888 174.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.58 -179.48 5.31 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 114.05 -1.432 . . . . 0.0 110.514 -170.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 23' ' ' VAL . 7.2 p -69.81 136.63 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.824 167.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -79.8 -38.3 33.34 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.612 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.4 m -167.69 132.64 1.88 Allowed 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.62 1.168 . . . . 0.0 108.862 -169.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.436 HG21 ' HD2' ' A' ' 21' ' ' TYR . 57.7 mt -85.24 133.13 30.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.959 0.504 . . . . 0.0 110.549 177.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB3' HD23 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -83.78 -46.99 11.61 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.444 0.698 . . . . 0.0 110.043 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.598 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 18.9 ptpt -156.75 162.55 39.76 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-O 120.849 0.357 . . . . 0.0 111.298 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -119.92 171.37 8.48 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.592 0.757 . . . . 0.0 109.621 171.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -170.73 134.76 1.06 Allowed 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.466 0.706 . . . . 0.0 109.796 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 19' ' ' VAL . 85.1 t -85.92 115.84 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.6 tpt180 -143.0 144.39 32.28 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.133 1.373 . . . . 0.0 108.579 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.2 pttp 51.18 26.04 2.71 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 125.924 1.689 . . . . 0.0 114.056 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 81.17 15.23 77.44 Favored Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.308 -0.405 . . . . 0.0 113.299 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -135.86 157.66 46.3 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.562 1.145 . . . . 0.0 108.07 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 14' ' ' VAL . 24.9 t -98.55 112.3 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 118.966 0.803 . . . . 0.0 109.568 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -95.74 150.86 19.92 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.457 1.103 . . . . 0.0 109.944 -177.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.436 ' HD2' HG21 ' A' ' 9' ' ' ILE . 52.1 m-85 -133.8 121.16 21.43 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.926 0.89 . . . . 0.0 109.291 -178.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD23 ' HB3' ' A' ' 10' ' ' ARG . 33.0 tp -68.93 105.12 2.27 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 171.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 6' ' ' VAL . 8.8 m -101.11 115.18 42.33 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 124.665 1.186 . . . . 0.0 111.388 -172.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.58 120.56 21.16 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 176.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 59.0 m95 -77.57 144.0 37.89 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.124 0.57 . . . . 0.0 111.024 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -56.68 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.101 0.961 . . . . 0.0 111.649 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.44 -40.91 2.26 Favored Glycine 0 C--N 1.345 1.063 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.659 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 70.7 m95 -71.61 119.74 75.79 Favored Pre-proline 0 CA--C 1.549 0.912 0 CA-C-O 118.46 -0.781 . . . . 0.0 110.339 -176.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -53.64 163.18 2.94 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 123.516 2.811 . . . . 0.0 113.289 -177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -71.62 18.58 0.28 Allowed 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.938 2.425 . . . . 0.0 114.494 -174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -89.28 -29.48 19.16 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 122.948 0.499 . . . . 0.0 110.03 164.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -88.75 -5.2 58.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.015 0.926 . . . . 0.0 111.312 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.8 p -64.5 118.97 9.56 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 122.849 0.46 . . . . 0.0 110.153 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 31.1 p -89.88 165.96 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.73 0.812 . . . . 0.0 110.641 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -100.02 113.86 26.75 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 170.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 40' ' ' HIS . 31.9 mt-10 -123.41 132.0 24.29 Favored Pre-proline 0 CA--C 1.543 0.706 0 C-N-CA 123.442 0.697 . . . . 0.0 110.025 177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HA ' ' O ' ' A' ' 19' ' ' VAL . 58.9 Cg_endo -68.98 170.83 14.76 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.518 2.145 . . . . 0.0 112.48 178.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -50.71 -35.04 29.25 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 124.025 0.93 . . . . 0.0 112.013 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.35 -30.61 57.68 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.003 -176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -82.74 -13.76 55.74 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 122.552 0.341 . . . . 0.0 110.63 -175.208 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 47' ' ' VAL . 2.5 mt -69.76 150.22 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.159 0.583 . . . . 0.0 110.2 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.31 -31.35 43.2 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -170.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -148.71 143.82 17.64 Favored Pre-proline 0 CA--C 1.552 1.043 0 C-N-CA 122.438 0.295 . . . . 0.0 110.422 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.446 ' HA ' HG12 ' A' ' 47' ' ' VAL . 9.8 Cg_endo -52.69 -31.64 51.4 Favored 'Trans proline' 0 C--N 1.386 2.503 0 C-N-CA 123.983 3.122 . . . . 0.0 114.445 173.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.1 ptm85 -63.32 -27.58 69.42 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.609 0.364 . . . . 0.0 110.833 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 86.1 mt -79.84 -41.68 25.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.909 0.884 . . . . 0.0 111.375 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.503 ' HB ' HD12 ' A' ' 41' ' ' ILE . 9.7 p -69.32 -33.68 58.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-N 118.102 0.41 . . . . 0.0 110.926 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.2 ptp -77.18 -21.66 53.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 122.803 0.441 . . . . 0.0 110.942 174.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.638 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.24 -17.02 51.25 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.187 0.995 . . . . 0.0 112.835 -177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 86.4 t80 -56.22 -57.6 11.53 Favored 'General case' 0 CA--C 1.553 1.063 0 O-C-N 123.3 0.375 . . . . 0.0 110.041 173.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -85.55 -28.75 24.69 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.361 0.664 . . . . 0.0 111.663 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 8.2 tp10 -67.18 -52.62 39.17 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.433 0.693 . . . . 0.0 110.906 -177.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' A' ' 53' ' ' LYS . 11.4 mmpt? -80.2 -42.68 22.87 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.699 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 60.32 98.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.802 1.241 . . . . 0.0 109.721 -173.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.559 1.312 0 C-N-CA 124.821 1.249 . . . . 0.0 113.519 -174.373 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 . . . . . 0 N--CA 1.478 0.968 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 60.36 23.86 13.37 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 125.185 1.394 . . . . 0.0 112.538 176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.8 p -153.03 121.02 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.649 0.78 . . . . 0.0 109.783 176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.87 91.15 3.55 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.1 167.39 21.94 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.198 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.538 HG12 HD13 ' A' ' 46' ' ' LEU . 14.7 p -77.6 150.67 5.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.541 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.02 -57.18 11.55 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.179 0.592 . . . . 0.0 109.501 171.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 75.6 m -162.24 137.77 7.32 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.624 1.17 . . . . 0.0 108.938 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.543 HG21 ' HD2' ' A' ' 21' ' ' TYR . 70.4 mt -85.32 103.67 12.55 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 167.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -62.91 -47.87 81.43 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.564 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 20.8 ptmt -161.65 164.21 29.4 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.975 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.97 153.48 49.44 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 169.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -148.84 135.93 20.02 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.323 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HB ' HG22 ' A' ' 19' ' ' VAL . 5.2 p -86.07 116.61 29.3 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 171.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -125.6 129.23 49.23 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.9 pttp 52.69 28.07 5.88 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 126.182 1.793 . . . . 0.0 112.951 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 92.54 7.84 62.96 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.066 178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.56 112.76 18.4 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.498 0.719 . . . . 0.0 110.755 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.679 HG22 ' HB ' ' A' ' 14' ' ' VAL . 19.7 t -70.69 112.43 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 CA-C-O 121.275 0.56 . . . . 0.0 110.274 172.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 25.5 mt-10 -108.64 139.79 42.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.48 1.112 . . . . 0.0 108.87 178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.543 ' HD2' HG21 ' A' ' 9' ' ' ILE . 28.2 m-85 -112.62 111.37 22.13 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.063 0.945 . . . . 0.0 110.373 -174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 46.3 tp -66.76 104.96 1.44 Allowed 'General case' 0 C--O 1.24 0.603 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 173.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.6 m -102.58 132.46 48.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.614 0.766 . . . . 0.0 110.52 -176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -85.28 117.46 24.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.564 -1.198 . . . . 0.0 109.05 174.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 66.6 m95 -78.26 142.08 38.1 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 170.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -58.04 -26.37 62.37 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -163.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.56 -26.86 1.54 Allowed Glycine 0 C--N 1.343 0.965 0 CA-C-O 120.062 -0.299 . . . . 0.0 112.941 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.735 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 14.5 m95 -71.95 128.22 89.61 Favored Pre-proline 0 CA--C 1.554 1.099 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -175.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -63.66 166.86 14.66 Favored 'Trans proline' 0 CA--C 1.566 2.09 0 C-N-CA 123.468 2.779 . . . . 0.0 113.215 -176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -46.87 -27.38 5.67 Favored 'Trans proline' 0 C--N 1.394 2.956 0 C-N-CA 124.37 3.38 . . . . 0.0 115.812 178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.65 -37.48 82.48 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.762 0.425 . . . . 0.0 111.793 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -91.09 -2.28 57.63 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.476 0.71 . . . . 0.0 111.899 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.9 m -66.87 115.43 6.63 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.2 p -94.64 157.15 16.1 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.481 0.712 . . . . 0.0 111.321 -171.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.0 m95 -93.31 100.15 12.55 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 173.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.13 118.83 66.43 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.901 1.28 . . . . 0.0 109.622 177.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.31 -178.67 0.9 Allowed 'Trans proline' 0 C--N 1.374 1.884 0 C-N-CA 122.515 2.143 . . . . 0.0 112.944 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -65.22 -14.73 61.37 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.4 0.68 . . . . 0.0 112.792 -175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 12.1 pt-20 -89.27 -20.73 23.75 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.722 0.809 . . . . 0.0 111.644 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.436 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 25.6 m170 -94.69 11.6 30.7 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.477 0.711 . . . . 0.0 111.825 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.589 HD13 ' HB ' ' A' ' 47' ' ' VAL . 45.6 mt -75.05 131.49 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 122.994 0.518 . . . . 0.0 109.745 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.13 -30.96 49.61 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HG ' ' A' ' 46' ' ' LEU . 7.4 t70 -159.66 143.39 10.68 Favored Pre-proline 0 CA--C 1.557 1.229 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.14 -171.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -46.61 -46.18 18.22 Favored 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 124.798 3.666 . . . . 0.0 114.223 175.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.484 ' HA ' ' HG2' ' A' ' 48' ' ' MET . 11.0 ptp85 -70.99 -16.26 62.62 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -172.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.538 HD13 HG12 ' A' ' 6' ' ' VAL . 89.6 mt -75.37 -48.8 21.31 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.25 0.62 . . . . 0.0 111.108 176.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.589 ' HB ' HD13 ' A' ' 41' ' ' ILE . 2.8 p -71.11 -41.15 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.68 0.392 . . . . 0.0 111.633 -177.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.484 ' HG2' ' HA ' ' A' ' 45' ' ' ARG . 23.5 ptm -70.21 -18.47 63.17 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 123.097 0.248 . . . . 0.0 110.723 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.486 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -67.3 -25.14 65.89 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.501 0.721 . . . . 0.0 111.799 177.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.564 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 66.1 t80 -52.0 -55.88 17.71 Favored 'General case' 0 CA--C 1.56 1.358 0 C-N-CA 122.96 0.504 . . . . 0.0 111.611 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -88.42 -7.47 56.56 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.275 0.63 . . . . 0.0 111.898 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 13.1 tp10 -90.0 -24.22 21.29 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.256 0.622 . . . . 0.0 111.01 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 72.2 mmtt -97.52 159.51 14.88 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.486 0.714 . . . . 0.0 109.317 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -80.79 -38.1 29.1 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.347 0.659 . . . . 0.0 109.798 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.25 1.093 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -176.041 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -67.17 -22.87 65.73 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.58 0.752 . . . . 0.0 111.478 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -76.97 100.29 2.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -94.17 99.33 11.61 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 -177.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -129.27 177.83 6.88 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.611 0.764 . . . . 0.0 110.803 -173.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.481 HG12 HD13 ' A' ' 46' ' ' LEU . 10.5 p -69.02 151.34 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.651 0.78 . . . . 0.0 110.971 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.78 -55.75 30.85 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.474 0.654 . . . . 0.0 109.306 170.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 37.5 p -175.5 148.35 0.92 Allowed 'General case' 0 C--O 1.241 0.648 0 CA-C-N 114.152 -1.385 . . . . 0.0 108.662 178.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.3 mt -74.88 113.8 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 169.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.49 ' HD2' HD23 ' A' ' 22' ' ' LEU . 3.6 tmt_? -62.18 -53.48 54.63 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.307 1.043 . . . . 0.0 108.793 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -159.9 163.14 34.53 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.086 179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -110.23 174.45 5.86 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 171.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -167.38 136.9 2.77 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.506 1.123 . . . . 0.0 108.812 168.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 19' ' ' VAL . 48.0 t -86.35 114.48 25.91 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -127.98 133.55 49.2 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.6 pttp 46.58 36.2 3.48 Favored 'General case' 0 N--CA 1.505 2.288 0 C-N-CA 125.21 1.404 . . . . 0.0 113.705 -178.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 71.05 23.13 78.41 Favored Glycine 0 C--N 1.352 1.423 0 CA-C-N 115.338 -0.847 . . . . 0.0 113.699 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -132.06 120.47 22.42 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 124.503 1.121 . . . . 0.0 108.13 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG22 HG22 ' A' ' 14' ' ' VAL . 12.0 t -78.29 110.79 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -105.23 145.62 30.39 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.074 0.95 . . . . 0.0 109.218 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -123.26 115.93 22.53 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.09 0.956 . . . . 0.0 109.898 -169.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' A' ' 10' ' ' ARG . 38.8 tp -68.66 106.87 2.77 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.7 m -100.86 142.17 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 123.345 0.658 . . . . 0.0 111.557 -175.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -96.4 124.12 40.29 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.113 -0.948 . . . . 0.0 109.682 175.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 84.3 m95 -84.34 130.75 34.77 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.35 -64.0 1.04 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.48 1.112 . . . . 0.0 113.229 -169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.56 33.53 5.11 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.042 -0.527 . . . . 0.0 113.097 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.497 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 90.1 m95 -138.73 141.79 31.89 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.603 0.761 . . . . 0.0 110.444 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.77 162.22 22.53 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 123.514 2.809 . . . . 0.0 113.099 176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.47 -3.38 10.0 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 123.316 2.677 . . . . 0.0 114.522 -175.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -72.91 -19.72 61.22 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.525 0.33 . . . . 0.0 111.535 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -89.5 3.75 51.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.563 0.745 . . . . 0.0 111.74 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 82.3 p -64.03 103.05 0.55 Allowed 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.272 0.558 . . . . 0.0 110.269 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.2 p -103.19 146.69 28.03 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.134 0.974 . . . . 0.0 110.934 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -87.19 125.88 34.45 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 172.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -127.88 134.74 26.54 Favored Pre-proline 0 N--CA 1.471 0.619 0 C-N-CA 123.191 0.596 . . . . 0.0 109.487 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -68.69 175.64 6.93 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 122.29 1.994 . . . . 0.0 112.851 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -54.92 -29.3 55.95 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 124.539 1.136 . . . . 0.0 112.26 -178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.45 -20.47 40.25 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.734 0.814 . . . . 0.0 113.001 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -83.05 -18.71 38.75 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 122.445 0.298 . . . . 0.0 111.708 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.8 mt -61.48 135.1 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 O-C-N 123.699 0.624 . . . . 0.0 111.11 -170.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -75.24 -22.86 57.57 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.077 -170.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -164.53 144.51 6.16 Favored Pre-proline 0 CA--C 1.555 1.172 0 C-N-CA 122.814 0.446 . . . . 0.0 110.725 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -48.33 -33.32 22.06 Favored 'Trans proline' 0 C--N 1.382 2.307 0 C-N-CA 124.586 3.524 . . . . 0.0 114.803 171.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.1 ptm85 -65.8 -21.93 66.53 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.179 0.192 . . . . 0.0 111.44 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.481 HD13 HG12 ' A' ' 6' ' ' VAL . 79.1 mt -79.83 -46.66 16.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.396 0.679 . . . . 0.0 110.773 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.75 -45.09 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 123.347 0.404 . . . . 0.0 110.664 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 26.1 ptm -66.79 -29.3 69.21 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.791 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -62.28 -23.25 66.6 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.075 0.95 . . . . 0.0 112.607 -176.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -57.81 -40.43 79.93 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 122.99 0.516 . . . . 0.0 110.889 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -97.65 -31.39 12.31 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.763 0.825 . . . . 0.0 112.23 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -77.73 -42.54 33.93 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.702 0.801 . . . . 0.0 110.702 -170.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -80.98 -19.18 44.62 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.737 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.42 83.88 7.56 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.552 1.035 0 C-N-CA 123.801 0.84 . . . . 0.0 109.174 -177.489 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 N--CA 1.478 0.951 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 67.63 7.87 5.96 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 125.141 1.376 . . . . 0.0 112.826 -176.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.5 p -173.67 140.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.782 1.233 . . . . 0.0 109.176 -178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -150.4 155.45 39.61 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.568 0.747 . . . . 0.0 109.806 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.82 178.33 7.57 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.005 0.922 . . . . 0.0 109.935 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.494 HG21 ' HB ' ' A' ' 23' ' ' VAL . 7.1 p -66.53 150.2 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.378 0.671 . . . . 0.0 110.051 172.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -65.71 -44.59 85.64 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.981 0.512 . . . . 0.0 111.494 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 t -171.58 172.86 4.88 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.529 0.732 . . . . 0.0 110.03 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 73.5 mt -105.09 127.43 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.866 0.867 . . . . 0.0 109.716 -179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.509 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.7 OUTLIER -68.47 -54.6 15.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.028 0.931 . . . . 0.0 109.733 178.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.546 ' HA ' ' HE1' ' A' ' 50' ' ' TYR . 21.3 ptmt -161.83 162.29 29.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.835 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -106.6 173.11 6.46 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 171.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.9 ttt85 -157.32 137.97 13.11 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.129 -0.942 . . . . 0.0 109.767 170.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 19' ' ' VAL . 63.0 t -86.59 113.74 24.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.673 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.61 141.07 21.57 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -176.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.8 ptpp? 56.95 26.17 11.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.532 1.533 . . . . 0.0 112.422 -173.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 74.34 16.92 79.69 Favored Glycine 0 C--N 1.354 1.546 0 CA-C-N 115.065 -0.971 . . . . 0.0 113.147 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -134.82 138.71 44.49 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.131 0.573 . . . . 0.0 110.878 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 14' ' ' VAL . 52.7 t -80.59 111.03 16.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 174.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 31.7 mt-10 -107.14 142.96 36.0 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.465 1.106 . . . . 0.0 109.31 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -116.57 121.16 40.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.844 0.857 . . . . 0.0 110.855 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.509 HD23 ' HD2' ' A' ' 10' ' ' ARG . 26.5 tp -72.5 107.71 5.18 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.323 1.049 . . . . 0.0 109.548 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.494 ' HB ' HG21 ' A' ' 6' ' ' VAL . 5.3 m -91.86 124.31 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.775 0.83 . . . . 0.0 112.128 -175.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -76.96 112.77 13.94 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.421 1.089 . . . . 0.0 110.86 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 86.0 m95 -76.76 128.98 35.65 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.997 0.427 . . . . 0.0 110.283 -177.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -59.46 -25.67 64.58 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.864 1.266 . . . . 0.0 113.579 -168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -130.82 16.92 5.27 Favored Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.104 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 68.8 m95 -127.12 147.39 61.58 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 117.703 0.751 . . . . 0.0 110.216 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.63 155.89 56.06 Favored 'Trans proline' 0 CA--C 1.566 2.106 0 C-N-CA 122.427 2.084 . . . . 0.0 112.028 172.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 -6.88 14.15 Favored 'Trans proline' 0 C--N 1.385 2.455 0 C-N-CA 123.15 2.567 . . . . 0.0 114.481 -173.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -69.51 -26.87 64.75 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.948 0.499 . . . . 0.0 111.48 173.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -88.82 -12.74 41.12 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.97 0.908 . . . . 0.0 111.5 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.1 m -58.52 127.05 30.22 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 122.925 0.49 . . . . 0.0 110.712 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 39.0 p -105.94 160.31 15.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.421 1.089 . . . . 0.0 110.819 -173.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 88.1 m95 -100.08 113.51 26.18 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.659 0.784 . . . . 0.0 110.203 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -112.84 123.63 33.37 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 122.872 0.469 . . . . 0.0 110.247 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 19.1 Cg_endo -57.85 170.69 1.89 Allowed 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.851 2.367 . . . . 0.0 113.434 174.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -53.69 -23.34 11.2 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.653 1.181 . . . . 0.0 113.302 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -69.37 -35.55 75.94 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.1 1.8 56.98 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.381 0.672 . . . . 0.0 112.596 -169.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.573 HD13 ' HB ' ' A' ' 47' ' ' VAL . 11.8 mt -63.52 125.87 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -73.12 -39.31 65.84 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 123.914 0.759 . . . . 0.0 111.227 -171.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' H ' HD12 ' A' ' 46' ' ' LEU . 10.7 t70 -147.35 138.1 12.85 Favored Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.065 0.546 . . . . 0.0 109.652 -174.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 43' ' ' ASP . 2.9 Cg_endo -46.31 -38.67 20.67 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 124.506 3.471 . . . . 0.0 114.871 174.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.0 ptm180 -63.74 -20.4 65.72 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -173.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.426 HD13 HG12 ' A' ' 6' ' ' VAL . 52.3 mt -75.17 -52.3 11.29 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.121 0.968 . . . . 0.0 111.059 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.6 p -65.03 -35.79 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.536 -177.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.8 ptp -76.17 -34.59 59.35 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.78 0.432 . . . . 0.0 110.475 178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.36 -30.94 71.98 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 123.525 0.73 . . . . 0.0 111.012 178.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.546 ' HE1' ' HA ' ' A' ' 11' ' ' LYS . 30.8 t80 -51.74 -54.15 31.59 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.246 175.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -88.55 -16.47 32.52 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.273 0.629 . . . . 0.0 112.069 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -82.17 -47.63 12.27 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.113 0.565 . . . . 0.0 110.997 -178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.8 mmpt? -70.61 99.06 1.59 Allowed 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.059 0.457 . . . . 0.0 109.822 -175.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.74 1.2 52.95 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.675 1.19 . . . . 0.0 111.715 -178.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.555 1.154 0 C-N-CA 123.964 0.905 . . . . 0.0 110.063 177.573 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 . . . . . 0 N--CA 1.484 1.24 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -83.07 29.71 0.47 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.184 0.993 . . . . 0.0 112.815 -176.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.34 93.74 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -96.44 84.08 3.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.865 0.84 . . . . 0.0 108.93 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -140.54 -177.52 5.09 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.392 1.477 . . . . 0.0 108.673 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.66 HG21 ' HB ' ' A' ' 23' ' ' VAL . 13.1 p -61.47 141.25 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 117.947 0.339 . . . . 0.0 110.721 174.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -69.16 -49.42 56.93 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.785 0.434 . . . . 0.0 110.964 -176.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.8 m -156.61 168.37 27.6 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.483 0.713 . . . . 0.0 109.909 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 67.0 mt -109.51 119.56 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 167.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.531 ' HD2' HD23 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -69.65 -63.26 1.11 Allowed 'General case' 0 C--O 1.242 0.693 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.569 ' HA ' ' CE1' ' A' ' 50' ' ' TYR . 20.1 ptmt -148.14 162.77 38.75 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.142 0.577 . . . . 0.0 110.486 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -118.04 174.2 6.34 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -161.01 140.52 10.59 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.831 1.252 . . . . 0.0 108.583 173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 19' ' ' VAL . 41.8 t -85.8 116.05 28.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.186 -1.412 . . . . 0.0 107.186 171.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.17 120.36 22.14 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 -170.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 pttp 46.14 37.67 4.14 Favored 'General case' 0 N--CA 1.506 2.374 0 C-N-CA 125.476 1.511 . . . . 0.0 114.105 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.83 0.9 83.25 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 115.702 -0.681 . . . . 0.0 114.285 175.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.27 125.47 29.35 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.161 0.984 . . . . 0.0 108.686 -178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG22 HG22 ' A' ' 14' ' ' VAL . 32.8 t -76.19 121.37 28.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 35' ' ' TRP . 23.4 mm-40 -98.1 146.52 25.48 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.382 1.073 . . . . 0.0 109.271 176.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 75.2 m-85 -124.53 111.07 15.25 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.688 0.795 . . . . 0.0 109.295 -173.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD23 ' HD2' ' A' ' 10' ' ' ARG . 43.2 tp -63.49 107.99 1.25 Allowed 'General case' 0 C--N 1.341 0.216 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 170.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.66 ' HB ' HG21 ' A' ' 6' ' ' VAL . 2.1 m -104.48 147.78 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 C-N-CA 124.084 0.954 . . . . 0.0 111.771 -172.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -105.61 109.38 21.33 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 85.9 m95 -84.55 140.64 31.27 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.162 0.585 . . . . 0.0 109.784 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -56.57 -58.29 8.67 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.69 1.196 . . . . 0.0 112.783 -169.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.85 34.52 5.58 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 116.425 -0.352 . . . . 0.0 112.808 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.5 m95 -135.94 127.11 17.05 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 123.626 0.77 . . . . 0.0 109.5 174.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 160.86 12.21 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.294 2.662 . . . . 0.0 112.393 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -64.62 2.08 1.44 Allowed 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 123.254 2.636 . . . . 0.0 115.331 -174.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -75.15 -29.64 60.54 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 122.82 0.448 . . . . 0.0 111.163 169.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -89.77 4.91 48.25 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.069 0.947 . . . . 0.0 111.176 177.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.0 m -63.8 101.01 0.33 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.005 0.522 . . . . 0.0 109.729 172.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 32.4 p -91.96 167.17 12.3 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.296 1.038 . . . . 0.0 110.522 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 67.9 m95 -105.63 107.56 18.62 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 173.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -109.65 140.96 22.68 Favored Pre-proline 0 N--CA 1.479 0.984 0 C-N-CA 123.111 0.565 . . . . 0.0 110.419 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.65 176.76 7.01 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.765 2.31 . . . . 0.0 113.849 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -54.98 -26.76 38.95 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 125.12 1.368 . . . . 0.0 112.62 178.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -88.44 -16.86 31.71 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.833 0.853 . . . . 0.0 112.713 -175.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -89.32 -15.52 33.24 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 119.238 -0.41 . . . . 0.0 112.002 178.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD13 ' HB ' ' A' ' 47' ' ' VAL . 9.2 mt -60.34 123.47 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 123.561 0.538 . . . . 0.0 109.644 -175.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.06 -29.03 65.94 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 123.889 0.743 . . . . 0.0 112.869 -169.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -152.27 138.53 11.86 Favored Pre-proline 0 CA--C 1.555 1.146 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.17 -29.51 37.67 Favored 'Trans proline' 0 C--N 1.382 2.336 0 C-N-CA 124.422 3.415 . . . . 0.0 114.597 174.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -66.27 -26.42 67.33 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.715 0.406 . . . . 0.0 111.199 -177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.8 mt -79.16 -43.98 22.88 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.259 1.023 . . . . 0.0 111.087 -175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.5 p -70.31 -33.89 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.071 179.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 19.4 ptm -76.68 -33.9 58.25 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 119.272 -0.394 . . . . 0.0 110.31 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -61.72 -24.76 67.0 Favored 'General case' 0 C--N 1.369 1.414 0 C-N-CA 123.881 0.872 . . . . 0.0 111.051 177.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 11' ' ' LYS . 47.8 t80 -53.52 -50.72 64.84 Favored 'General case' 0 CA--C 1.551 1.001 0 O-C-N 123.323 0.389 . . . . 0.0 111.396 173.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -86.79 -39.59 15.77 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.333 0.653 . . . . 0.0 110.991 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.591 ' HB3' ' HA ' ' A' ' 49' ' ' ALA . 10.9 tp10 -54.81 -42.04 71.38 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.633 1.573 . . . . 0.0 110.777 -177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 66.6 mmtt -89.64 -53.51 4.49 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.148 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -90.7 77.08 6.38 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.2 0.6 . . . . 0.0 110.891 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 . . . . . 0 CA--C 1.551 1.003 0 C-N-CA 123.935 0.894 . . . . 0.0 109.621 176.574 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.59 ' HG2' ' HG3' ' A' ' 2' ' ' GLN . 36.7 tt0 . . . . . 0 N--CA 1.475 0.822 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.59 ' HG3' ' HG2' ' A' ' 1' ' ' GLU . 49.2 mt-30 67.51 3.98 3.6 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.585 1.154 . . . . 0.0 113.237 176.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 58.0 t -90.49 90.98 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -94.79 131.83 40.21 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 174.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.513 ' HB1' HD21 ' A' ' 46' ' ' LEU . . . -133.07 151.04 52.06 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.605 1.162 . . . . 0.0 108.881 -177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.616 HG12 HD13 ' A' ' 46' ' ' LEU . 13.0 p -67.57 146.12 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 122.257 0.223 . . . . 0.0 110.689 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.464 ' HG2' ' HG2' ' A' ' 26' ' ' LYS . 54.0 mm-40 -63.96 -50.43 68.65 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.926 0.49 . . . . 0.0 110.597 174.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.4 m -159.27 132.28 6.99 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.244 0.618 . . . . 0.0 110.005 -175.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' A' ' 50' ' ' TYR . 74.0 mt -78.76 113.47 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 163.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.455 ' HD2' HD23 ' A' ' 22' ' ' LEU . 1.2 tmt_? -70.35 -42.36 71.94 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.603 0.761 . . . . 0.0 111.026 -175.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 50' ' ' TYR . 19.4 ptpt -163.66 163.58 24.27 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.779 0.432 . . . . 0.0 110.986 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.73 161.0 32.65 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.478 0.711 . . . . 0.0 110.954 177.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -162.95 142.71 9.03 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.969 0.908 . . . . 0.0 108.572 -176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 19' ' ' VAL . 57.3 t -93.46 129.4 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.63 126.23 27.06 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt 52.63 24.12 2.98 Favored 'General case' 0 N--CA 1.5 2.047 0 C-N-CA 126.325 1.85 . . . . 0.0 113.574 -175.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.75 -11.29 70.82 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 113.775 -178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.45 123.4 43.69 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.829 0.852 . . . . 0.0 108.745 175.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 14' ' ' VAL . 7.3 p -86.64 121.81 38.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 C-N-CA 123.05 0.54 . . . . 0.0 110.857 -177.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 37' ' ' PRO . 4.8 mp0 -99.08 155.58 17.37 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.587 0.755 . . . . 0.0 110.572 173.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.435 ' HE1' ' HG3' ' A' ' 38' ' ' GLU . 71.1 m-85 -131.92 105.15 7.26 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.213 1.405 . . . . 0.0 108.208 -178.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.455 HD23 ' HD2' ' A' ' 10' ' ' ARG . 48.6 tp -61.16 106.15 0.57 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.617 0.767 . . . . 0.0 109.762 176.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' HB ' HG21 ' A' ' 6' ' ' VAL . 16.7 m -96.67 131.78 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 123.863 0.865 . . . . 0.0 111.023 -176.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -90.05 122.92 33.48 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.115 0.966 . . . . 0.0 110.674 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 28' ' ' TRP . 88.2 m95 -67.99 156.3 37.6 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 123.015 0.526 . . . . 0.0 110.971 174.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HG2' ' HG2' ' A' ' 7' ' ' GLU . 66.9 mttm -67.21 -28.01 67.72 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -170.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -152.52 29.52 0.85 Allowed Glycine 0 C--N 1.34 0.772 0 O-C-N 123.114 0.259 . . . . 0.0 112.624 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.562 ' HB2' ' HB2' ' A' ' 25' ' ' TRP . 92.3 m95 -120.68 140.83 31.18 Favored Pre-proline 0 N--CA 1.477 0.906 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 176.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -60.64 161.4 21.24 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.051 2.501 . . . . 0.0 112.8 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -59.03 -16.8 34.56 Favored 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 123.612 2.875 . . . . 0.0 114.571 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -64.13 -31.05 72.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 122.982 0.513 . . . . 0.0 112.122 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -86.38 -19.97 28.94 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.417 0.687 . . . . 0.0 111.097 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.1 m -66.54 124.74 23.63 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.494 0.718 . . . . 0.0 110.446 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.0 p -114.61 153.69 29.68 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.013 0.925 . . . . 0.0 111.474 -170.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 20' ' ' GLU . 86.2 m95 -80.29 102.32 9.45 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.921 0.888 . . . . 0.0 109.979 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.7 mm-40 -98.66 116.81 65.24 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 123.498 0.719 . . . . 0.0 110.404 178.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.592 ' HA ' ' HA ' ' A' ' 20' ' ' GLU . 37.6 Cg_endo -64.02 177.4 1.94 Allowed 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.731 2.287 . . . . 0.0 113.298 178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' ILE . 4.5 mt-10 -66.43 -6.4 14.41 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 -178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -91.92 -20.7 21.13 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.591 0.756 . . . . 0.0 111.564 175.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -106.01 27.37 8.65 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 123.957 0.903 . . . . 0.0 111.823 -175.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 HD11 ' HG2' ' A' ' 38' ' ' GLU . 20.2 mt -84.34 136.79 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 177.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -81.67 -28.86 33.35 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.014 0.526 . . . . 0.0 111.178 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 41' ' ' ILE . 5.2 t70 -162.05 135.21 4.57 Favored Pre-proline 0 CA--C 1.562 1.414 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 -175.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -53.41 -31.22 56.66 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 124.046 3.164 . . . . 0.0 115.179 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.6 ptt85 -68.94 -19.11 64.17 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.616 HD13 HG12 ' A' ' 6' ' ' VAL . 64.1 mt -76.06 -47.91 22.86 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.531 0.732 . . . . 0.0 111.049 178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 41' ' ' ILE . 7.4 p -68.22 -39.15 80.69 Favored 'Isoleucine or valine' 0 C--O 1.244 0.789 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.181 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptm -70.01 -36.93 75.49 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.897 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.548 ' O ' ' HG2' ' A' ' 53' ' ' LYS . . . -50.47 -49.48 55.17 Favored 'General case' 0 C--N 1.372 1.547 0 C-N-CA 124.659 1.184 . . . . 0.0 111.946 -173.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.527 ' O ' ' HG2' ' A' ' 54' ' ' GLU . 29.9 t80 -54.62 -60.93 2.69 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 118.042 0.383 . . . . 0.0 110.793 -176.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -78.76 -9.83 59.57 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.657 0.783 . . . . 0.0 112.497 -173.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.4 tp10 -88.39 -36.63 16.46 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.298 0.639 . . . . 0.0 110.061 176.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.548 ' HG2' ' O ' ' A' ' 49' ' ' ALA . 9.9 mmpt? -77.82 -16.18 58.51 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.023 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 50' ' ' TYR . 13.9 mm-40 -73.9 90.07 1.91 Allowed 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 CA--C 1.558 1.265 0 C-N-CA 123.668 0.787 . . . . 0.0 110.532 -175.352 . . . . . . . . 0 0 . 1 stop_ save_